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Variation in healthcare delivery is ubiquitous in the United States. Two fundamental questions in 
health policy discussions today are these: what determinants explain the marked variation in 
healthcare spending across hospital referral regions in the United States and whether or not 
greater healthcare spending improves patient outcomes. This dissertation extends prior 
research by (1) examining the role that health behaviors and modifiable risk factors play in 
explaining differences in Medicare spending across regions and (2) evaluating how differences 
in spending affect beneficiaries’ physical, cognitive, and mental health and functioning.  
 
Dissertation aims were addressed using data from the Health and Retirement Study (HRS), a 
nationally representative longitudinal survey of older Americans, and this was linked to Medicare 
claims and regional spending characteristics from The Dartmouth Atlas of Health Care. 
Medicare beneficiaries age 65 or older and enrolled in traditional (fee-for-service) Medicare 
comprised the study population. Price-adjusted Medicare spending was measured as spending 
for care in a variety of settings (inpatient, skilled nursing facilities, outpatient, physician office, 
home health, and hospice) as well as spending for durable medical equipment. Analytic 
methods included regression-based decomposition techniques and instrumental variables 
analysis.  
 
In assessing the determinants of regional variation in spending, Medicare beneficiaries’ 
observable characteristics (e.g., sociodemographics, behavioral risk factors, health status 
factors) collectively explained 17% of regional differences in price-adjusted Medicare spending. 
Behavioral risk factors, specifically—smoking status, alcohol consumption, body mass index, 
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and physical activity—explained 7% of the difference in spending between higher- and lower-
spending regions.  
 
In examining the effects of Medicare spending on health and functional outcomes among 
hospitalized Medicare beneficiaries (after adjusting for confounding due to health status), a 10% 
increase in price-adjusted, 1-year post-admission Medicare spending was associated with 
reductions in the probability of new limitations in instrumental activities of daily living (-1.96 
percentage points; 95% confidence interval [CI], -3.88 to -0.03; P=0.05), new depressive 
symptoms (-2.31 percentage points; 95% CI, -4.04 to -0.59; P=0.009), and 1-year mortality (-
2.02 percentage points; 95% CI, -3.57 to -0.46; P=0.01). There was no association between 
higher Medicare spending and self-rated health status, limitations in activities of daily living, pain, 
or cognitive functioning. 
 
This dissertation provides policymakers with new information about the importance of behavioral 
risk factors as determinants of regional variation in Medicare spending and the impact of 
healthcare spending on multiple dimensions of health and functioning in Medicare beneficiaries. 
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The current and perennial debate about variation in regional healthcare spending in the United 
States had its origin in an unexpected discovery many years ago. In 1938, J. Alison Glover 
discovered that the rate of tonsillectomies among British school children varied widely across 
localities in England and Wales.1 It was not until 40 years later that this same phenomenon, 
coupled with the recognition that differences in physicians’ medical practices were largely 
responsible for the varying tonsillectomy rates, was noted by John Wennberg and Alan 
Gittelsohn to exist in Vermont.2 Since Wennberg’s pioneering work describing small area 
variation in the 1970s,2 an abundance of research has been conducted relating to geographic 
variation in healthcare delivery.  In 2013, publication of the Institute of Medicine’s (IOM) 
landmark report, Variation in Health Care Spending: Target Decision Making, Not Geography, 
reinvigorated public interest in the relationship between geography and healthcare delivery and 
spending.3 Two fundamental questions that are a part of health policy discussions today are 
these: what causes the marked variation in healthcare spending across the 306 hospital referral 
regions (HRRs) in the United States and whether or not greater healthcare spending improves 
patient outcomes.4-8 This dissertation addresses both of these questions. 
 
With passage of the Affordable Care Act in 2010, an influx of aging Americans into Medicare, 
and recent projections that Medicare spending will continue to grow,9 policymakers face 
renewed pressure to understand and curtail Medicare spending.3,10 Variation in utilization has 
been viewed as an opportunity to reduce plausibly unnecessary spending; in fact, some experts 
estimate that 30% of healthcare spending could be eliminated if higher-spending regions 
reduced the amount of care they deliver to the level of lower-spending regions of equal 
quality.10-12 Nevertheless, substantial debate still surrounds the causes and consequences of 
variation as well as the requisite policy interventions.13 That debate has been framed by a 
handful of published studies that principally assessed mortality as an outcome and used 
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methods and administrative datasets that restricted causal inference. Despite their equivocal 
results about whether more spending improves health, these articles have had—and continue to 
have—a significant impact on healthcare policymaking.  
 
This dissertation asserts that a deeper understanding is needed of the factors contributing to 
regional variation in healthcare spending and the relationship between healthcare spending and 
outcomes. First, this deeper understanding is needed because the impact of health behaviors 
and modifiable risk factors on variation in spending and utilization is largely unknown. Smoking, 
alcohol consumption, obesity, and limited physical activity—all of which are prevalent within the 
rapidly aging population—are prominent examples of these patient determinants of utilization.14 
Despite recognition that behavioral risk factors vary geographically and have contributed 
substantially to the growth of healthcare spending over the past 20 years,15-17 these factors have 
not been adequately assessed as possible drivers of regional variation in spending.18 Second, 
the current literature is constrained by its reliance on mortality as the primary measure of health; 
yet many costly and discretionary treatments mainly impact quality of life, rather than length of 
life.  
 
This dissertation seeks to advance this current body of evidence by (1) studying a broad set of 
behavioral risk factors in addition to health outcomes, (2) using rigorous econometric methods 
to estimate causal effects and address unobserved confounding, and (3) leveraging the unique 
opportunities afforded by accessing data in the Health and Retirement Study (HRS), a 
nationally-representative longitudinal survey of older Americans that is linked to Medicare claims. 
 
DISSERTATION AIMS 
The aims of this dissertation were to: 
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1. Examine the literature on the determinants of healthcare spending and geographic 
variation in spending as well as evidence of the relationship between the intensity of 
healthcare spending and patients’ outcomes;  
2. Develop a deeper understanding of the role of behavioral risk factors in explaining 
differences in spending and utilization across regions; and 
3. Examine the effects of healthcare spending on the physical, cognitive, and mental health 
and functioning outcomes of hospitalized Medicare beneficiaries. 
 
ORGANIZATION OF THE DISSERTATION 
This dissertation consists of five chapters. This chapter, Chapter 1, introduces the dissertation 
topic, enumerates the aims of the dissertation, and describes the structure and format of the 
dissertation, as contained in subsequent chapters.  
 
Chapter 2 reviews the literature and, from this, develops a conceptual framework that informs 
subsequent analyses (Aim 1).  
 
Chapter 3 and Chapter 4 comprise the main empirical manuscripts of the dissertation and 
address the determinants and consequences of geographic variation in healthcare spending, 
respectively. For both manuscripts, data from the HRS were linked to Medicare claims and 
regional spending characteristics from The Dartmouth Atlas of Health Care.19 More specifically, 
Chapter 3 investigates the role of behavioral risk factors as possible explanatory factors of 
geographic variation in Medicare spending (Aim 2). The difference in cumulative spending on 
Medicare beneficiaries between 2004 and 2006 in higher- versus lower-spending regions was 
examined using a regression-based decomposition technique originally developed in the labor 
economics field. This method assesses whether regional differences in Medicare spending 
derive from observable differences in beneficiary characteristics, such as their behavioral risk 
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factors, or whether these differences derive from provider practice patterns that treat similar 
beneficiaries differently. Chapter 4 examines the association between Medicare spending during 
and after acute hospitalization and beneficiaries’ subsequent health and functioning (Aim 3). 
Instrumental variables analysis, a common econometric technique, was used to reduce 
confounding related to beneficiaries’ health status and severity of illness and to estimate causal 
effects of spending differences on self-rated health, functional status, pain, cognition, 
depressive symptoms, and mortality. Both manuscripts contain appendices detailing extensive 
additional analyses that were designed to evaluate the robustness of the main results. The main 
findings of both manuscripts were supported by these sensitivity analyses.  
 
Chapter 5 summarizes the key findings of the dissertation, reiterates their policy implications, 
offers recommendations for future research, and concludes the dissertation. When viewed as a 
whole, these manuscripts provide policymakers with important, new information about the 





CHAPTER TWO: LITERATURE REVIEW (MANUSCRIPT #1) 
 
DETERMINANTS AND CONSEQUENCES OF GEOGRAPHIC VARIATION IN 










Two fundamental questions in health policy are what causes differences in spending across 
regions and whether higher healthcare spending improves patient outcomes. This manuscript 
provides a narrative review of the literature pertaining to the determinants and consequences of 
geographic variation in healthcare spending. Demand-side and supply-side determinants of 
spending and of regional variation in spending are reviewed, with an emphasis on those factors 
particularly salient to the subsequent manuscripts that comprise this dissertation. Studies 
assessing the effects of healthcare spending on outcomes are heterogeneous, and the 
evidence that additional spending improves outcomes is equivocal. Confounding by unobserved 
severity of illness and the predominant use of mortality as the primary representation of health 
status are important limitations of this literature. Based on this literature review, Ronald 
Andersen’s widely known behavioral model of health services utilization is then selected, 
adapted, and applied to the study of geographic variation in healthcare spending. Specifically, 
this proposed conceptual model diagrams the pathways through which elements of the 
healthcare system and predisposing characteristics of the population influence healthcare 




Geographic variation in healthcare use across the United States is pronounced, pervasive, and 
persistent.3 Medicare beneficiaries living in high-spending regions receive significantly more 
healthcare than those in low-spending regions.2,10 The Institute of Medicine’s (IOM) landmark 
2013 report, Variation in Health Care Spending: Target Decision Making, Not Geography, 
returned the topic of practice variation to the fore of health policy. Two fundamental questions in 
health policy are what causes the marked variation in spending across the 306 hospital referral 
regions (HRRs) in the United States and whether greater healthcare spending improves patient 
outcomes.  
 
The objective of this manuscript was to critically review and synthesize pertinent literature 
pertaining to this dissertation and to inform the empiric manuscripts that follow. The organization 
of this manuscript corresponds to the 3 Specific Aims described previously: determinants of 
geographic variation, with a focus on distinguishing demand-side versus supply-side factors 
(Part 1), and consequences of geographic variation (Part 2). Following Part 2, a conceptual 
framework is presented that integrates this literature.  
 
METHODS 
To identify relevant literature for this review, searches were conducted using PubMed, Google 
Scholar, and, to a lesser extent, EconLit. Given the likelihood of wide-ranging gray literature 
related to this topic, searches were also conducted through specific organizations: Kaiser 
Family Foundation, Centers for Medicare and Medicaid Services (CMS), Congressional 
Research Service, American Hospital Association, Robert Wood Johnson Foundation, and the 
IOM. Key search terms included the following: geographic variation, regional variation, practice 
variation, healthcare spending, healthcare utilization, treatment intensity, Medicare, and 
outcomes. Numerous reviews of the geographic variation literature exist,13,20-23 including the 
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recent IOM report that was extensive in its coverage.3 These existing reviews provided a basis 
for structuring this manuscript. The bibliographies of these reviews were also examined and 
references were extracted with the belief that these references would be emblematic of key 
literature.  
 
PART 1. DETERMINANTS OF GEOGRAPHIC VARIATION IN SPENDING AND UTILIZATION 
The causes and determinants of geographic variation in healthcare spending have been a 
source of growing interest in the literature.  A recent exhaustive review of the subject by 
Manning and colleagues (2012)18 (as a supplement to the IOM’s report on geographic variation) 
informs the focused review that follows. The determinants of variation in utilization can be 
broadly dichotomized into demand-side and supply-side factors.24,25 We discuss both of these 
sets of determinants of utilization and their propensity to vary regionally. Pertinent issues related 
to defining or measuring these determinants are also discussed. 
 
Demand-side Factors 
Demand-side factors relate to how and why patients seek health care, and they include 
underlying health status, sociodemographic characteristics (including access to health 
insurance coverage), health behaviors and modifiable risk factors, and patient preferences 
related to health care. These factors are typically accounted for as independent variables in 
regression models.  
 
Health Status 
Health status of the patient is a crucial determinant of demand for health care.26 Sicker patients 
require (and receive) more care and incur greater spending and utilization. As such, it is vital to 
adjust for health status when comparing the healthcare utilization of different patients, and when 
comparing utilization of patients in different regions because health also varies 
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geographically.27,28 For example, using data from the National Health Interview Survey, Kachan 
and colleagues (2014)27 found significant state-level regional differences in health-related 
quality of life among older Americans. Other studies have demonstrated that functional status29 
and life expectancy30 also vary geographically. The empirical challenges posed by health status 
as a confounder are discussed in Part 2 of this literature review. Here, discussion centers on 
how health status is measured and how it contributes to regional variation in healthcare 
spending and utilization. 
 
Health status can be measured in a variety of ways.  For example, patients’ medical diseases 
are commonly elicited from administrative records, survey data, or electronic health records. 
Comorbid diseases can be identified using the International Classification of Diseases, Ninth 
Revision (ICD-9) or 10th Revision (ICD-10) codes present in administrative records, and these 
codes are also used in classification systems such as Medicare’s Hierarchical Condition 
Categories,31 the Charlson Index,32 or Elixhauser comorbidities.33 Comorbid diseases commonly 
controlled for in analyses include the following: hypertension, diabetes, coronary heart disease, 
stroke, cancer, and acute myocardial infarction.18 Patients can also self-report health status, and 
such self-reporting may be less subject to concerns about bias related to physician diagnostic 
practices.34 Finally, it is not uncommon for health status variables to be measured at the 
population level (such as incidence of disease or mortality rates within specific regions or 
geographical areas) when data for these variables are not available for individuals.  
 
Despite consensus that health status is a key driver of healthcare utilization, debate persists 
amongst scholars about the importance of health status for explaining regional variation in 
utilization. That debate is framed by two divergent viewpoints: the first is the belief that regional 
differences in utilization are really due to underlying (unmeasured) differences in patient health 
status and that better risk adjustment would attenuate unexplained differences; the second is 
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the belief that regional differences in utilization are real, cannot be explained away solely by 
case mix, and that supply-side factors such as physician aggressiveness are the key 
determinants.35 Consequently, studies have come to divergent conclusions about the extent to 
which health status accounts for variation in utilization across regions.36,37 This variability is a 
result of these studies using different methods to control for health status and using different 
geographic units of analysis. 
 
Two studies, relying on the same data source (the Medicare Current Beneficiary Survey 
[MCBS]) provide insight into the extent to which health status can explain regional variation in 
healthcare spending. Sutherland and colleagues (2009)38 used MCBS data (at the patient level) 
and included blood pressure, diabetes, body mass index, smoking history, and self-rated health 
as health status measures; they found that these variables explained 18% of the regional 
differences in spending between the highest and lowest quintiles. Subsequently, Zuckerman 
and colleagues (2010)37 used the MCBS but added over 10 additional health variables; they 
found that health status factors explained 29% of the differences in spending between regions in 
high versus low Medicare spending quintiles. The recent publication of a paper by Reschovsky 
and colleagues (2013)39 that implemented a modified version of Medicare’s Hierarchical 
Condition Categories model (by including only diagnoses that were less susceptible to physician 
discretionary behavior) concluded that population health could explain more than 75% to 85% of 
spending variation. However, the Reschovsky study did not directly address the concern that 
there is a lower threshold for diagnosis in higher intensity regions and that use of the 
Hierarchical Condition Categories model may over-adjust regional differences in spending.40,41  
 
The intensity of patient observation varies regionally, and diagnoses recorded in medical 
records and claims do not exclusively reflect underlying disease burden; as such, the use of 
clinical or claims-based diagnoses for risk adjustment may introduce additional biases.42,43 Song 
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and colleagues (2010)42 exploited a natural experiment in which patients were moving to higher-
versus-lower intensity regions; they demonstrated that those patients moving to higher-intensity 
regions experienced more physician visits, diagnostic tests, and imaging exams—and accrued 
more diagnoses—following their move, but with no differences in their 3-year post-move 
mortality. Similarly, Welch and colleagues (2011)43 demonstrated a positive relationship 
between regional intensity of patient observation (measured as frequency of physician visits, 
diagnostic tests, laboratory exams) and diagnoses of chronic illnesses, as well as an inverse 
relationship between the regional frequency of diagnoses and case fatality from chronic disease.  
 
In light of this evidence that diagnostic practices vary regionally, it is evident that patients in 
higher-intensity regions accumulate more diagnoses and thus appear sicker. However, this is an 
artifact of diagnostic differences rather than differences in underlying health status, suggesting a 
judicious application of risk adjustment approaches in studies related to geographic variation. 
Recent work by John Wennberg and colleagues (2013)44 compared a standard method of risk 
adjustment to a visit-corrected method that specifically adjusts for bias induced by observational 
intensity using HRR-level data on the frequency of physician visits as a proxy for intensity of 
observation. They compared the standard method to the visit-corrected method for three 
common risk adjustment schemes: the Charlson Index, the Iezzoni chronic condition count, and 
the Hierarchical Condition Categories risk score.  They found that the visit-corrected method 
reduced the bias associated with observational intensity.  David Wennberg and colleagues 
(2014)41 developed two new approaches to health risk adjustment—a poverty index and a 
population health index (consisting of self-reported illness, obesity, smoking status, and the 
regional incidence of admission to the hospital for hip fractures and strokes). Both approaches 
outperformed the standard Hierarchical Condition Categories index in terms of explaining and 
reducing variation in age-sex-race adjusted mortality and in terms of not exhibiting bias due to 
observational intensity.  A final limitation of using diagnoses recorded in administrative data as 
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risk adjusters is that they do not discriminate between different disease severity levels, even 
among patients with the same diagnosis, and so concerns related to omitted variables bias 




Sociodemographic characteristics—age, sex, race and ethnicity, education, and income or 
wealth—are associated with health status and healthcare utilization. It is well recognized that 
advancing age is associated with increased utilization of hospital and physician services and 
pharmaceuticals, secondary to chronic diseases and functional declines.46 Nevertheless, 
greater use of effective therapies, such as antihypertensive drugs, may reduce downstream 
utilization for complications of untreated or undertreated chronic diseases. As such, the 
independent effect of age on utilization is not clear-cut.46 Sex is associated with different care-
seeking behaviors and perceptions of illness,47 social roles, and prevalence of illnesses. Some 
studies have identified that women utilize more healthcare services than men;48 but conversely, 
other studies have found similar utilization in men and women after women’s childbearing years 
and men’s higher age-specific mortality rates were controlled for.49 There are marked disparities 
in the U.S. in both the quantity and quality of health care received by racial and ethnic 
minorities.50 Regional patterns of racial disparities in healthcare utilization rates have also been 
documented.51-53 Age, sex, and race are frequently controlled for when studying health 
expenditures or outcomes of interest. For example, the Dartmouth Atlas of Health Care adjusts 
its measures for age, sex, and race to capture differences in beneficiary characteristics across 
regions.54 These same demographic characteristics often also serve as proxy measures for 
health status when health status variables are not available.  
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Factors such as education, income, and wealth and can affect decisions to access and utilize 
health care (and vary demographically and geographically).18,55 Socioeconomic status, whether 
measured by education or income, is associated with healthcare utilization and health behaviors 
as well as morbidity and mortality.56 Education can improve health through better occupational 
factors and work conditions, and an increased knowledge about lifestyle factors, health 
behaviors, and social-psychological resources.57 Greater income can improve access to health 
insurance and consequently to health care;58 it can also provide for better living environments, 
educational opportunities, and recreation, all of which tend to enhance health status. Because 
measuring income accurately poses a challenge (owing to reporting biases) and only provides a 
cross-sectional view of an individual’s financial resources, wealth can be used an alternative 
measure of socioeconomic status that is also significantly associated with health,59 but not 
necessarily with utilization.60 Income or wealth also represent important variables to control for 
when studying healthcare utilization and may also act indirectly as proxies for other 
determinants of health.61 Insurance coverage status is related to income to the extent that 
access to different types of health insurance or health insurance programs is often related 
employment or income levels (e.g., access to Medicaid as a form of coverage for lower income 
Americans as opposed to private insurance coverage for employed or higher income 
Americans). Health insurance in turn affects access to care,62 and access is known to influence 
spending and utilization. Fisher and colleagues (2003)5 found that residing in a higher-spending 
region was associated with worse access.  
 
In sum, differences in how sociodemographic variables are measured and coded and which are 
included or excluded—all of these preclude clear conclusions about the significance of these 
factors in explaining regional variation in spending.18 The IOM report found that controlling for 
age and sex had a minor effect on geographic variation in spending; similarly, race and income 
had minor effects once health status was accounted for in analyses.3  
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Health Behaviors and Modifiable Risk Factors 
Health behaviors and modifiable risk factors, such as smoking, drinking, obesity, and exercise 
affect utilization of health care and are directly correlated with health.63 Smoking is associated 
with increased visits to specialists and hospitalizations.64 Heavy alcohol users disproportionately 
utilize emergency and acute healthcare services64,65 Compared with nonobese patients, obese 
patients incur more visits to primary care physicians and specialists, use more diagnostic 
services, and have greater charges in aggregate and across a range of services.66 
 
Individuals who smoke, drink alcohol in excess, have unhealthy diets, are obese, and are 
physically inactive are at greater risk of developing chronic diseases, such as heart disease, 
stroke, cancer, and diabetes.67-69 Smoking increases the risk of numerous diseases, including 
cardiovascular and cerebrovascular disease (such as, acute myocardial infarction and stroke), 
respiratory diseases (such as, chronic obstructive pulmonary disease and asthma), cancers 
(particularly lung cancer70), and diabetes, among many others.71,72 Alcohol consumption at light-
to-moderate levels may be associated with health benefits, such as decreased risk of 
cardiovascular diseases (though what constitutes “moderate” varies across studies).73-75 
However, heavy drinking is associated with increased risk of cardiovascular disease, stroke, 
cancer, gastrointestinal diseases, and the health consequences of injuries. 76-80 Field and 
colleagues (2001)81 followed individuals for 10 years and found that obesity was associated with 
increased risk of diabetes, gallstones, hypertension, heart disease, colon cancer, and stroke.  
 
Once acquired, the chronic diseases caused by or linked to these behavioral risk factors can 
precipitate healthcare utilization related to treatment and management.82 For example, in 2005 
the U.S. spent $190 billion on healthcare expenses related to obesity.83 These same chronic 
diseases are also significant sources of morbidity and mortality in the U.S., especially among 
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older Americans.14,84 Mokdad and colleagues (2004),84 in revisiting a seminal 1993 article by 
McGinnis and Foege,85 found that tobacco, alcohol consumption, and poor diet and physical 
inactivity accounted for nearly half of all deaths in the U.S. in 2000.   
 
There are a variety of ways to define and measure behavioral risk factors. For example, 
smoking is often measured as duration in years (current age minus age since first smoked 
regularly), elapsed time since quitting for past smokers (age since last smoked minus age since 
first smoked), and pack-years (number of years smoked multiplied by the number of packs per 
day).  Common approaches for measuring alcohol consumption include the quantity-frequency 
approach86 (number of drinks per day times the number of drinking days per week) and the 
CAGE screening assessment (2 or more positive responses to a 4-item instrument suggests 
alcohol abuse/dependence).87 Physical activity is often queried by asking individuals their 
frequency, duration, and intensity of exercise, often within a specific interval of time (such as a 
week).88 Obesity is typically measured using body mass index (BMI) classification; for example, 
a BMI between 25 and 29.9 is considered overweight and greater than 30 is considered obese. 
As described by Riekert and colleagues (2014),88 the measurement of health behaviors can be 
objective or subjective. Objective and direct measurement (as the behavior happens) occurs 
with behavioral observation or electronic monitoring. Objective and indirect measurement (after 
the behavior has occurred) occurs with biochemical analysis. Subjective and indirect 
measurement occurs via different forms of individual or proxy ratings of past behavior. Self-
reporting and rating of health behaviors is common in large and longitudinal surveys because it 
facilitates data collection, but, because it does not directly measure behaviors, it is subject to 
reporter and recall bias.  
 
Behavioral risk factors also vary by demographic characteristics, socioeconomic status, and 
geography.15 For example, Victor Fuchs acknowledged years ago that Utah has a relatively low 
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prevalence of smoking and drinking, characteristics he attributed to the high proportion of 
Mormons residing in the state who disavow these practices.28 Few studies in the geographic 
variation literature have included measures of behavioral risk factors and the importance of 
these factors in explaining variation in healthcare spending and utilization remains uncertain.18  
 
Patient Preferences 
Patient preferences related to health care can also influence healthcare utilization. If patient 
preferences vary regionally, then including measures of preferences would be analytically 
important.18 For example, if patients in certain regions of the country demand more office visits, 
greater use of intensive care, more diagnostic tests and imaging, and prefer to see specialists, 
then supply of these resources, such as physicians, beds, and imaging equipment, would 
increase to satisfy the preference for greater intensity of care.89  
 
Preferences are defined differently across studies, and few datasets collect measures of patient 
preferences across an array of geographic areas. Dartmouth researchers have defined 
preference-sensitive care as, “interventions for which there is more than one option and where 
the outcomes will differ according to the option used.”90 Fisher and Wennberg (2003)91 argue 
that preference-sensitive care is a problem of misuse (rather than underuse or overuse) and 
occurs when medical theory is strong but actual medical evidence (such as from experimental 
or observational studies) is variable or ambiguous. As such, preference-sensitive care involves 
two or more treatment alternatives and necessitates tradeoffs between different sets of risks 
and benefits. Elective surgery is archetypical of preference-sensitive care. Ideally, treatment 
selection would be based on informed patient decision-making buttressed by the best available 
information; in practice, physicians’ opinions about outcomes and their beliefs about patient 
preferences likely drives the decision.  
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While the extent to which patient preferences explain variation in spending or utilization remains 
unclear, limited empiric research suggests that patient preferences account for relatively little of 
the variation in spending across regions. Baker and colleagues (2014)92 found that patients’ 
preferences explain 5% of the variation in Medicare spending across hospital referral regions. 
Using national survey data, Anthony and colleagues (2009)89 found significant variation among 
Medicare beneficiaries in their preferences for utilizing health care, but the distribution of 
preferences was similar across regions. Examining EOL care, Barnato and colleagues (2007)93 
failed to identify a significant relationship between regional expenditures for EOL care and 
patient preferences. Recent work by Cutler and colleagues (2013)94 demonstrated that 
physician preferences were significantly more important for explaining geographic variation in 
utilization when compared with patient preferences.  
 
Supply-side Factors 
The geographic variation literature has emphasized supply-side factors (those attributable to 
physicians and provider organizations) as the important determinants of geographic variation. 
As such, many proposed policy interventions to curb unwarranted variation are inculcated with a 
belief that the greatest opportunities to reduce variation in utilization and improve quality can be 
achieved by influencing how providers deliver care. This focus underlies such initiatives as pay-
for-performance, value-based purchasing, and accountable care organizations. Supply-side 
determinants exist at multiple levels and include clinician factors, hospital factors, and regional 
factors; these levels are not necessarily mutually exclusive because of their nested structure 
(i.e., clinicians work within hospitals, and hospitals define important aspects of the region 
wherein they operate). Healthcare prices are also an important supply-side determinant of 




Clinician factors refer to determinants of utilization at the individual provider level. Clinician—
namely physician—factors are generally agreed to account for a significant fraction of 
healthcare costs. As an occupational group, physicians constitute a fraction of 1% of the U.S. 
labor force, but collectively they influence roughly 17% of national GDP by directing how over 
90% of every healthcare dollar is spent.95 Supplier-induced demand is offered as one 
explanation of how physicians influence healthcare expenditures. In a principle-agent framework, 
the physician (or other healthcare provider) who is incentivized to provide more services, can 
shift a patient’s demand curve beyond what the patient would otherwise demand. However, the 
existence of large variations in utilization in countries that have national healthcare systems 
(and few incentives for physicians to use more care) potentially contradicts suppler-induced 
demand as a putative explanation of variation in utilization. 
 
At the bedside, physicians may recommend different treatments due to differences in diagnostic 
skill, beliefs in treatments’ efficacies,94,96 tolerance of medical uncertainty,97 medical school and 
residency programs attended, and cultural/social norms related to specific diseases and 
treatments.98 For example, physicians’ varying tolerances of clinical uncertainty may result in 
different predilections for ordering tests or for using procedures that directly affect utilization.95,99  
 
In the absence of clear evidence about the best therapeutic option, local norms and institutional 
culture may emphasize one alternative over others.100 Burke and colleagues (2010)101 and de 
Jong and colleagues (2003 and 2006)102,103 identified that professional interactions amongst 
providers are important factors in guiding care decisions. For example, physicians who train in 
the same programs are more likely to share similar treatment patterns compared with 
physicians who train in different programs.94,96,104 These practice patterns change slowly and 
may not evolve over time to a common norm.105 In addition, providers (perhaps, especially 
trainees) may emulate the practices of peers, superiors, or opinion leaders when deciding 
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among treatment approaches.106 Clinical practice guidelines and decision aids have been 
proposed as interventions to standardize knowledge and practice and to reduce practice 
variation, but there is little evidence that these approaches alone can achieve these aims.107,108  
 
The main question of import, however, is whether these factors vary across regions and 
whether physician preferences agglomerate geographically. While empiric work addressing this 
question remains limited, the recent study by Cutler and colleagues (2013)94 (mentioned 
previously), used strategic surveys of physicians and patients and demonstrated that 
physicians' preferences were geographically correlated and outweigh patients' preferences in 
explaining regional variation in utilization. Underlying physicians' treatment preferences were 
the physicians’ own apparently idiosyncratic beliefs about treatments' efficacies (which were 
often inconsistent with professional practice guidelines); this was in addition to physician-
perceived pressure to satisfy patients or referring physicians.  
 
Hospital Factors 
Two of the most salient hospital factors that contribute to differences in spending are a 
hospital’s ownership status and its resource supply.18 Ownership status of a hospital (i.e., 
whether a hospital is for-profit, not-for-profit, or government-operated) has been proposed as a 
source of variation in utilization. As suggested by Kenneth Arrow’s formative work (1963)109 on 
information asymmetries, if patients are unable to discriminate differences in quality between 
hospitals, then a hospital’s for-profit status could be perceived as an imperfect proxy signaling 
lower quality. In Arrow’s model, lower quality stems from a profit-focused orientation that would 
undermine spending on quality improvement.18 Newhouse (1970)110 later proposed that for-profit 
and not-for-profit hospitals have different objectives: for-profit hospitals seek to maximize profits, 
whereas not-for-profit hospitals seek to maximize quality of care and patient volumes. This 
theory implies that regions with more for-profit hospitals could have greater inpatient spending 
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and utilization in clinical areas that are more profitable. Some empirical analyses, such as an 
assessment by Sloan and colleagues (2001),111 found that for-profit hospitals were indeed more 
expensive than their not-for-profit or government-operated counterparts, but with no appreciable 
difference in quality. 
 
Bed supply has also been viewed as a driver of variation in spending and utilization, especially 
for acute care beds.112,113 Researchers at Dartmouth often describe such care as “supply-
sensitive” because the supply of a resource (e.g., hospital bed) influences utilization. Supply-
sensitive care is characterized by weak medical theory and medical evidence, a high per capita 
supply of the resource in question, and a variable importance of patient preferences.91  
Roemer’s Law—a bed built is a bed filled—is often invoked by studies finding that hospitals with 
more beds have greater utilization. Roemer’s law is at odds with the more conventional 
economic interpretation that believes inversely that supply follows demand. Manning and 
colleagues (2012) identify that there is a dearth of research on the causal chain underlying this 




Regional factors refer to factors best conceptualized at an area level because they either affect 
many providers and hospitals or are characteristics amalgamated over many providers or 
hospitals (e.g., practice norms, regulatory and legal climates, and financial incentives).117 Area-
level practice norms are epitomized by medical and surgical “signatures” for specific procedures, 
where physicians in specific areas use certain procedures at specific, stable rates that are 
unique to that area.90,118 There are also differences across regions in the distribution or density 
of providers and their type. Studies have shown that regions characterized by greater numbers 
of medical specialists have associated higher spending, and, conversely, that regions with 
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greater numbers of primary care providers have lower spending.5,18,119 The existence of medical 
schools, academic medical centers, and research institutions within a region is possibly relevant 
because of the way in which such organizations set local performance standards and socialize 
and train providers who subsequently populate the local market.120,121 David Molitor (2011)98 
demonstrated that cardiologists who migrate from one geographic region to other dissimilar 
regions (HRRs), practice more similarly to each other before the move versus after the move, 
suggesting that aspects of the first regional practice environment most strongly influence 
physician behavior. With this identification strategy, Molitor estimates that environmental factors 
are roughly twice as important for influencing physician behavior as physician-specific factors. In 
contrast, Grytten and colleagues (2003)122 examined primary care physicians in Norway and 
found that their practice styles were stable before and after moving to different municipalities. 
The divergent conclusions suggested by these studies may relate to underlying differences in 
the study populations (specialists versus generalists) or the inherent differences between the 
United States and Norway. Nevertheless, the factors influencing physician utilization patterns 
are diverse, multifactorial, and incompletely understood.  
 
Other characteristics operating at a regional level include malpractice environment, local 
emergency response systems, and decisions of local legislatures (e.g., certificate-of-need laws 
that affect purchase of expensive technology, capital expenditures, or medical school openings 
and closings).18 As these topics are not directly germane to the dissertation, they are not 
discussed further.  
 
Healthcare Prices 
Lastly, prices vary geographically. For example, providers in different regions face different input 
costs, such as land prices and wage rates.18 In prospective payment systems, such as inpatient 
care provided under Medicare, the price per episode for a specific diagnosis-related group 
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(DRG) reflects differences in input costs and market competition. Gottlieb and colleagues 
(2010)54 demonstrated that utilization rather than local price differences drive regional variation 
in spending within Medicare, a conclusion buttressed by the IOM report. In contrast, in the 
commercial insurance market, regional differences in prices explain an estimated 70% of the 
total geographic variation in spending.123 Price adjustment or standardization removes the 
effects of regional variation in input costs, such as those related to capital, labor, and overhead 
(rent and liability costs), and better reflects utilization of services.124 
 
PART 2. CONSEQUENCES OF GEOGRAPHIC VARIATION: EVALUATING THE SPENDING-
OUTCOME RELATIONSHIP 
Hussey and colleagues (2013)23 systematically reviewed the literature on the association 
between healthcare spending and patient outcomes, providing an important source of key 
references and topical organization for Part 2 of this literature review. In general, the literature 
on consequences of geographic variation in healthcare spending/utilization is heterogeneous; 
studies have used different data sources, levels of analysis (areas, providers, patients), 
dependent variables (quality measures of structure, process, or outcome), measures of costs or 
spending, and statistical methods (particularly with respect to adjusting for health status).23 This 
part of the manuscript reviews the types of spending and outcome measures commonly used, 
methods to address confounding (specifically, how different study designs account for health 
status), and key findings from the existing literature. 
 
Spending Measures 
In discussing spending measures, it is important to note that studies of the spending-outcome 
relationship have used different levels of analysis with which to assess the effects of spending. 
Hospital-level studies are among the most common, followed by area- or region-level studies.23 
Area-level analyses are highly variable. Some are conducted exclusively at the area- or region-
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level (e.g., by comparing cross-sectional average spending in a state to that of average quality), 
as in the studies by Baicker and Chandra (2004)119 and Cooper (2009).6 Other studies, such as 
the classic articles by Fisher and colleagues (2003),4,5 measured spending at the area-level 
(HRR) but examined patient-level outcomes. HRRs are commonly used regional/geographic 
designations in this literature. There are 306 HRRs in the U.S., which represent regional 
healthcare markets for tertiary medical care. They were originally defined as being the 
catchment areas around tertiary medical centers where patients were referred for major 
cardiovascular surgical and neurosurgical procedures.19  
 
Studies have used different terminology to describe healthcare spending. For example, 
expenditures, utilization, and costs are, at times, used interchangeably to describe a similar 
underlying construct. Expenditure, as used in the literature, is typically measured as the rate 
paid for a service (price) multiplied by the number of services provided (quantity).117 As such, 
regional variation in expenditures derives from regional variation in both price and quantity. 
Price-adjusted or price-standardized expenditures—that control for regional differences in 
prices—therefore more adequately reflect differences in utilization. Utilization, as used in the 
literature, is also commonly measured as counts (e.g., number of physician visits) or as rates of 
procedures in area-level analyses (e.g., number of surgeries performed per 1,000 beneficiaries).  
Cost is an ambiguous term and often implies a specific perspective (i.e., cost to whom, or 
spending from the perspective of a specific stakeholder), such as the cost to the patient, 
provider, or payer. Ultimately, these different terms, and the measures associated with them, 
seek to distinguish between patients receiving more versus less health care, irrespective of 
whether that measure is derived from the provider side (e.g., charges and accounting costs) or 
the payer side (e.g., Medicare expenditures or payments). As such, these measures are 
different representations of the intensity of healthcare services provided to and consumed by 
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patients. This is the intention when expenditure, utilization, and cost are used in the remainder 
of this manuscript.  
 
Measures of spending have been operationalized in a variety of ways: charges (the amount 
billed by providers to insurers);125-128 accounting costs from providers’ accounting systems;8,129-
150 care intensity indices (e.g., the Dartmouth Atlas’ End-of-Life Expenditure Index) that reflect a 
relative amount of resource use in the healthcare production function;4,5,151-161 and expenditures, 
measured as payments for healthcare services made by payers such as Medicare.6,119,162-179 
Charges reflect markups, and they likely overstate actual costs. Hussey and colleagues found 
that 39% of studies used accounting costs, 33% of studies measured expenditures, 21% used a 
care intensity index, and 7% used unadjusted charges.23 Accounting costs were predominantly 
used in studies where the hospital (or nursing home) was the level of analysis. In contrast, care 
intensity indices were predominantly used in area-level analyses, although several such studies 
also used expenditures as measures of spending.6,119,162,163  
 
Outcome Measures 
A variety of dependent variables have been used as representations of quality or “benefit” 
derived from spending. These include measures of structure, process, and outcome (following 
Donabedian’s model of healthcare quality),180 patient experience (including satisfaction), access, 
or composites of these variables.23 In general, the majority of studies used outcome measures 
of quality, with mortality being the most commonly used outcome.4,8,125,127,128,130,132-134,136-142,147,151-
153,158-160,162,165-167,170,179,181 
 
Mortality has been studied over a variety of timespans, from inpatient mortality,152,167 to 30-day 
mortality,166 to 1-year mortality, to 5-year mortality.181 In a prominent series of papers, Fisher 
and colleagues (2003)4,5 and Skinner and colleagues (2005)181 examined the association 
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between total Medicare spending and 1-year and 5-year mortality. In contrast, Kaestner and 
colleagues (2010)127 focused on 30-day mortality in conjunction with inpatient Medicare 
spending only, in order to limit confounding by other sources of spending outside of the inpatient 
setting. Importantly, the studies by Fisher and colleagues examined HRR-level, rather than 
hospital-level, intensity of spending patterns. This is germane to the issue of spending because 
patients discharged from hospitals following inpatient stays often continue receiving services 
(such as outpatient care) within their HRRs.  
 
Because the majority of studies have relied on administrative data, patient-reported outcomes 
and measures of physical, cognitive, and mental functioning (which are not commonly collected 
in such datasets) have received less attention in the literature. Such outcomes capture the 
elements of healthcare utilization that are not intended to alter the likelihood of survival, but 
rather to influence patients’ health and functioning. As exceptions, Fisher and colleagues (2003) 
and Hadley and colleagues (2011)179 used the Medicare Current Beneficiary Survey (MCBS) to 
examine patient-reported measures, such as access to care,5 satisfaction with care, and 
functional status.4 Functional status was measured using the Health Activities and Limitations 
Index (HALex).182 Other measures of functional status, namely activities of daily living (ADLs), 
were limited to studies conducted in nursing homes where data on ADLs are routinely collected 
as part of the Minimum Data Set.146,147,170 As one exception, Picone and colleagues (2003)142 
used binary indicators of ADL or instrumental ADL (IADL) limitations for a hospitalized patient 
population derived from the National Long-Term Care Survey linked to Medicare claims. The 
data used in this study are over 20 years old and do not provide current information about the 
effects of spending on ADL and IADL limitations in hospitalized patients. Taken together, there 
has been little emphasis in this literature on the non-mortality aspects of health status. 
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Methods to Address Confounding 
Confounding by unobserved differences in patient characteristics—particularly health status—is 
a central challenge facing studies whose goal is to assess the consequences of regional 
variation in healthcare spending. To date, there are no experimental studies examining how 
differences in the intensity of spending or utilization affect outcomes. Randomized experiments 
could resolve confounding by observable and unobservable health status, but would be 
impractical due to the logistical and ethical challenges of randomizing patients to different levels 
of intensity and then ensuring that clinicians provide care at those level of intensity.  
 
A central challenge of non-experimental research reported in this body of literature relates to 
addressing the endogeneity of spending measures. An endogenous explanatory variable is one 
that is correlated with the error term in a regression equation. Endogeneity can be caused by 
omitted variables, simultaneity, or measurement error.183 In this context, bias due to omitted 
variables occurs when important variables—such as severity of illness measures—are 
unobserved in the data but are likely correlated with both spending/utilization and health 
outcomes. Simultaneity (sometimes described as reverse causality) occurs when the underlying 
causal pathway is as likely to be directed from health to spending as it is from spending to 
health. Jonathan Skinner has identified that area-level studies that entail simple comparisons of 
outcomes between higher-spending and lower-spending regions may fall victim to reverse 
causality because the sickest regions tend to spend more on health care.181  
 
Confounding by severity of illness is difficult to overcome empirically. The geographic variation 
literature exhibits several approaches. These include multivariable regression analysis, which 
risk-adjusts only for the effects of observable health status (and the endogeneity problem is 
essentially ignored); natural experiments, whereby patients are assigned to exposures using a 
natural varying feature (not controlled by researchers) that is “as if” randomly assigned (such as 
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regional intensity of end-of-life expenditures);184 and instrumental variables estimation, which 
uses instrumental variables (observable variables that influence treatment or exposure but do 
not directly affect outcomes) to address unobservable health status.185,186 A complicating 
concern with all of these approaches, but especially with multivariable regression, is that 
diagnostic practices—those that identify common comorbidities used for risk adjustment in 
regression models—also vary regionally. The implications of this were discussed in Part 1 of the 
literature review. 
 
The majority of studies reviewed used multivariable regression adjustment.23 Zhang and 
colleagues (2009)168 used propensity score matching in an effort to reduce selection bias. 
Neither regression adjustment nor propensity scores ameliorate unobserved confounding.187 
Some studies used area- or region-level intensity measures as the key exposure variables. For 
example, Fisher and colleagues (2003)4,5 used “exposure” to an area-level price-adjusted End-
of-Life (EOL) Expenditure Index, which measured the intensity of care in the last 6 months of life 
(often called a “look-back” measure), as the main independent variable. This measure assumes 
that, across regions, all patients with an identical prognosis are equally ill, and so it intends to 
capture the part of regional variation in spending that is attributable to physician practice 
patterns rather than to regional differences in illness or price. The authors argue that this design 
naturally randomizes patients to different spending levels and therefore takes into account 
confounding by unobserved health status. The EOL Expenditure Index, and related measures 
(such as spending in the last 2 years, rather than in the last 6 months of life) have since been 
used in studies by Stukel and colleagues (2012) studying the association of hospital spending 
intensity with mortality and readmission rates in Ontario hospitals,188 O’Hare and colleagues 
(2010)189 in examining regional variation in end-stage renal disease treatment practices, and 
Hadley and colleagues (2011) in studying the relationship between cumulative Medicare 
spending and beneficiaries’ mortality and functional status.179 However, Bach and colleagues 
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(2004 and 2010)190,191 have criticized such look-back measures as misleading and argued that 
differences in subject selection and time period can bias results about the care provided to 
decedents. Other area-level measures have also been used.  Stukel and colleagues (2005)192 
used area-level cardiac catheterization or beta-blocker prescription rates as primary exposures. 
In a distinct natural experiment, Doyle and colleagues (2007)152 assessed the outcomes of 
patients who received care in healthcare systems not near their home; in this case, the patients 
were visitors to Florida who experienced heart attacks and were hospitalized; the study used 
multivariable regression as well as an alternative analysis using instrumental variables. 
A minority of studies used instrumental variables estimation as the analytic approach.23 An 
instrumental variable, or “instrument,” is an auxiliary variable that generates variation in the 
endogenous variable of interest but has no direct effect on the outcome variable(s) and is 
uncorrelated with unobserved confounders. The goal of this method is to determine how much 
of the variation in the endogenous variable is induced by the instrument itself (the so-called 
exogenous variation) and how that affects the outcome variable. The induced variation serves to 
identify the desired estimate.186 The concept of identification—in an econometric sense—refers 
to the possibility of estimating a causal effect by writing a parameter in terms of population 
moments that can be estimated using a sample of data generated by a data-generating 
process.193,194  
 
Examples of instruments used in these studies included care intensity indexes127,152,179 (such as 
the EOL Expenditure Index), physician visits or intensive care unit (ICU) days in the last 6 
months of life,181 ambulance referral patterns,150 hospital demand,143 the Medicare Wage Index 
and general overhead costs per day at the hospital level,195 and outcome values from previous 
years.130 Instrumental variable estimation, unlike ordinary least squares (OLS), can yield 
consistent estimates of the effect of spending on health outcomes. Consistent estimates are 
vital for informed policymaking. Because spending is endogenous and likely positively 
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correlated with unobserved severity of illness measures, the coefficient on spending would be 
biased toward showing that more spending worsens outcomes if estimated by OLS.179,193 In 
general, the literature supports the view that studies using more rigorous research designs, 
such as instrumental variables analysis, have found that additional healthcare spending is 
associated with improved outcomes.150,179,196-198  
 
Instrumental Variables Estimation  
Because of its importance within this literature, additional discussion about instrumental 
variables estimation methodology follows. Finding suitable candidate instruments is a key 
challenge of using instrumental variables estimation. An instrument should have two 
characteristics: validity and relevance.193 Instrument validity is based on whether the instrument 
is exogenous (i.e., uncorrelated with unobserved severity of illness) and has no direct effect on 
health outcomes (the exclusion restriction).186 For example, Hadley and colleagues (2011)179 
used the EOL Expenditure Index as an instrumental variable, an example of a measure of 
regional treatment intensity.  
 
Suitability of measures of regional spending or treatment intensity can be justified on the 
following grounds. First, evidence indicates that significant regional variation in spending and 
utilization persist even after accounting for a comprehensive set of patient characteristics and 
health status measures, suggesting that this variation reflects factors unrelated to patient health, 
such as supply-side practice patterns.37 Kelley and colleagues (2011)199 found that marked 
variation in EOL spending remained even after accounting for numerous risk-adjusters derived 
from Health and Retirement Study survey responses and Medicare claims. Second, physician 
factors and practice patterns are strongly associated with differences in spending across 
regions, supporting the viability of these candidate instruments. Sirovich and colleagues 
(2008)96 surveyed physicians in HRRs around the U.S. by using identical clinical vignettes and 
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asking participants about how they would treat the hypothetical patients. Physicians in higher-
spending regions were more likely to recommend discretionary services (e.g., tests of unproven 
benefit) and also to schedule more frequent return visits when compared to physicians in lower-
spending regions. Third, Fisher and colleagues (2003)4,5 demonstrated that the average 
baseline health of patients in different HRRs was similar across quintiles of EOL treatment 
intensity.  Stukel and colleagues (2005)192 similarly demonstrated that baseline heart attack 
severity was similar across regions characterized by widely varying treatment intensities. Both 
studies suggest that regional measures of treatment intensity do not directly affect health 
outcomes.200 Instrument validity is often justified on a theoretical basis, and many papers using 
instrumental variable estimation devote considerable explanation to justifying the validity of the 
chosen instruments. If valid instruments are not available, then instrumental variables estimation 
is not an appropriate analytic method. 
 
Instrument relevance is based on whether or not an instrument explains variation in the 
endogenous variable (whether it is positively or negative correlated with it).  Unlike validity, 
instrument relevance can (and should) be tested using the sample of data.193 Commonly used 
means of assessing instrument relevance include the partial R2 value, Cragg-Donald F statistic, 
and Kleibergen-Paap Wald statistic. The partial R2 is the R2 between the endogenous variable 
and the instrument after controlling for other covariates in the model. The Cragg-Donald F 
statistic and Kleibergen-Paap Wald statistic are tests for weak instruments; the Kleibergen-Paap 
Wald test is a robust analog of Cragg-Donald.  
 
A commonly used rule of thumb proposed by Staiger and Stock (1997)201 is that an F statistic 
below 10 suggests the possibility of a weak instrument problem. Stock and Yogo (2005)202 offer 
an alternative approach based on the Cragg-Donald F statistic in the case of a single 
endogenous variable (with the null hypothesis that the instruments are weak) and critical values 
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based on size distortion of the 5% Wald test. In the case of clustered standard errors, Baum and 
colleagues (2007)203 suggest either applying these critical values to the Kleibergen-Paap test 
with caution or using the original Staiger and Stock (1997) rule-of-thumb that the F statistic 
should be 10 or more.  
 
Findings from the Literature 
Findings from studies comprising the growing empirical literature examining the spending-
outcome relationship are found to present a mixed picture: some studies identify a positive 
association between spending and outcomes, while others found a negative or mixed 
association, and yet others found no association. In part, this equivocal evidence stems from the 
marked heterogeneity in study designs, data sources, and measures used. In general, studies 
finding a positive association between spending and outcomes (most commonly, mortality) had 
magnitudes conveying minimal clinical significance.23  
 
Negative, Null, and Mixed Findings 
Among those finding negative associations, Baicker and colleagues (2004)119 found a negative 
association between per capita Medicare spending and overall state quality ranking; and, on 
individual quality measures, they found either significant and negative associations or 
nonsignificant associations. Comparing HRRs in the highest- to the lowest-spending quintile 
based on the EOL Expenditure Index, Fisher and colleagues (2003)4,5 found that patients with 
acute myocardial infarction (AMI) receive a lower quality of care (were less likely to receive 
acute reperfusion, aspirin at admission or discharge, and ACE inhibitors at discharge). Higher-
spending regions were also less likely to provide flu immunizations, pneumonia immunizations, 
and Pap smears.5 They found that risk of death was worse for colorectal cancer and AMI 
patients and not significantly different for hip fracture patients in regions with higher EOL 
spending. But they found that functional status was not significantly different between the 
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highest- and lowest-spending regions.4 In a study specific to colorectal cancer that also used the 
EOL Expenditure Index, Landrum and colleagues (2008)153 found that greater spending intensity 
was significantly associated with increased non-cancer mortality but not significantly associated 
with all-cause or cancer-specific mortality. Looking at a process measure of chemotherapy 
receipt, they found that higher-spending regions had a greater propensity to use recommended 
care, but also nonrecommended and discretionary care. 
 
With regard to patient perceptions of care, Fowler and colleagues (2008)163 failed to find 
significant differences in the patient having a perceived unmet need for tests or treatments, or in 
a patient’s perceived quality of care (ambulatory care and overall care) when comparing the 
highest- and lowest-spending regions. In contrast, Fisher (2003)4 and Wennberg (2009)155 found 
that overall patient satisfaction or experience was negatively associated with care intensity. 
Similarly, Yasaitis and colleagues (2009)156 found that compared with patients in lower-intensity 
regions, those receiving health care in higher-intensity regions reported lower efficiency, 
satisfaction, overall quality of care, and patient centeredness, and lower ratings of physician-
patient communication.  
 
For the assumption and observed negative associations that more spending undermines 
outcomes, possible mechanisms are suggested by several studies showing that regions with 
higher utilization rates perform certain interventions in patient populations with lower underlying 
medical need—a signal of possible overuse.151 The burgeoning overuse literature204 is related to, 
though distinct from, the practice variation literature. Variation in utilization may imply, but does 
not prove, overuse; especially if differences in utilization are related to “appropriate” sources of 
variation, such as patient preferences.205 (Note: Patient preferences, and other determinants of 
variation in spending, were discussed in Part 1 of this literature review.) A systematic review by 
Keyhani and colleagues (2012)206 found limited evidence that inappropriate use of procedures 
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explains geographic variation in spending and utilization. By using a distinct conceptual 
framework focused on identifying systematic overuse of health care (i.e., utilization that is 
expected to have no health benefit and is likely to be the result of physician factors), Segal and 
colleagues (2014)207 developed an index of overuse at the HRR level and emphasized that 
overuse is a phenomenon that is distinct from that of utilization. They found that regional 




At a hospital level, numerous studies have found positive associations between higher costs 
and mortality. In assessing inpatient mortality, Romley and colleagues (2011)167 found that 
higher-spending hospitals had lower risk-adjusted inpatient mortality among patients 
hospitalized with diagnoses of acute myocardial infarction, congestive heart failure (CHF), 
stroke, gastrointestinal hemorrhage, hip fracture, and pneumonia. Similarly, Kaestner and Silber 
(2010)127 used instrumental variables analysis and found that among Medicare patients 
hospitalized for general, orthopedic, and vascular surgery or for CHF, stroke, and 
gastrointestinal bleeding, a 10% increase in hospital spending (charges) was associated with a 
3.1% to 11.3% decrease in 30-day mortality (depending on the disease). In a pair of studies 
analyzing data for hospitals in California, Mukamel and colleagues (2001 and 2002) found that 
additional spending per discharge was associated with lower 30-day mortality per 100 
discharges141 and that hospitals above the 50th percentile for cost per admission had lower 
mortality rates.140 Conversely, Schreyogg and colleagues (2010)195 analyzed spending during 
index hospitalizations for acute myocardial infarctions, using instrumental variables analysis; 
they found that lower costs were associated with a 0.63% increase in the risk of dying and a 
1.24% increase in the risk of readmission. Using longer intervals for outcome assessment, 
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Doyle and colleagues (2012)150 and Picone and colleagues (2003) found that increases in the 
cost of a hospital stay were associated with lower 1-year150 and 2-year142 mortality rates.  
 
Barnato and colleagues (2010)158 also assessed hospitals but instead used a revised EOL 
Expenditure Index (different from the one described previously that was developed by 
researchers at Dartmouth) rather than hospital cost, and they found that admission to higher 
EOL treatment intensity hospitals was associated with lower 30-day mortality. Stukel and 
colleagues (2012)188 also used a variant of the EOL Expenditure Index as the “primary exposure” 
to treatment intensity for adults hospitalized in Ontario hospitals for AMI, CHF, hip fracture, or 
colon cancer. They found reductions in mortality, readmissions, and cardiac event rates for 
patients admitted to higher-spending intensity hospitals. Using a similar measure of EOL 
intensity but at the county-level, Doyle (2007)152 found that a 10% increase in county EOL 
intensity was associated with a 0.3–percentage point decrease in mortality.  
Several other studies examined nonmortality outcomes. Carey and Burgess (1999)130 found 
improved outpatient follow-up rates 30 days after inpatient discharge (process measure) in 
hospitals with higher costs.  Hadley and colleagues (2011)179 evaluated the HALex score using 
MCBS data from 1992-2002 and instrumental variables estimation and found that more 
spending was associated with improved functional status. At a state level, Richard Cooper 
(2009)6 found that greater total per-capita healthcare spending in 2004 was associated with 
better state-level quality (based on Jencks quality rankings of health system performance). 
 
When viewed collectively, this literature presents an equivocal picture with respect to the 
question of whether greater intensity of spending or utilization—either at a hospital or in a 
region—is associated with improved quality of care and patient outcomes. The studies reviewed 
are heterogeneous in their study designs, employing a diversity of spending and outcome 
measures, patient populations, and empirical strategies. Two important observations can be 
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drawn from this part of the review, and these observations can inform future research: (1) 
unobserved health status should be dealt with through more rigorous study designs and 
methods, and (2) there is relative dearth of information about the effect that spending has on 




A conceptual framework was developed based on the preceding literature review that integrates 
determinants of regional variation in utilization and identifies key variables. No single unifying 
conceptual framework underlies research in medical practice variation.13 This literature 
emanates from a diversity of disciplines: epidemiology, beginning with John Wennberg’s 
pioneering work on small area variation;2 economics, which has sought to parse out supply and 
demand factors contributing to geographic variation;22 and sociology, which has emphasized the 
social context influencing physicians’ decision-making behavior as it relates to practice 
variation.94,102,103,209 These perspectives are not mutually exclusive, but have employed different 
theories and methodologies to study practice variation.  
 
Acknowledging these differing traditions, Ronald Andersen’s widely known behavioral model of 
health services utilization,210 which has an extensive history in health services research for 
studying utilization, was adapted. Early versions of this model focused on measures of access, 
emphasizing utilization as the endpoint of interest; later versions focused on health outcomes as 
the endpoints of interest. Andersen's conceptual model accommodates determinants of 
utilization that exist at multiple levels (e.g., individual and regional factors). One criticism of 
Andersen’s original model was that it was biased towards assuming that increased utilization 
was always better.211 Andersen has defended the model, believing it is non-normative regarding 
utilization,210 and the adaptation of Andersen’s model here makes no such normative judgments.  
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Figure 2.1 depicts a modified version of Andersen’s model. The grey boxes represent the 
important conceptual areas originally described by Andersen, and the white boxes beneath 
indicate the key factors pertinent to the study of variation in spending or utilization. For brevity, 
not every demand-side or supply-side factor discussed in Part 1 of the literature review is 
depicted in Figure 2.1; the bullets are examples of some of the most important factors.  
 
In this model, the environment comprises elements of the healthcare system, such as region- 
and hospital-level factors. These interact with characteristics of the population, including the 
population’s predisposing characteristics, such as its sociodemographics, health behaviors, and 
care preferences; enabling resources (factors that support or hinder use of health care), such as 
access to care, health insurance, and income or wealth; and its need, which has both perceived 
and evaluative components. Perceived need is how an individual interprets his or her health 
status and makes decisions to seek professional assistance, whereas evaluative need reflects 
physicians’ professional judgment and the type and amount of care needed by the patient.210 
Therefore, “need” can refer to the onset of an unambiguous disease necessitating treatment or 
intervention (e.g., heart attack)—what Andersen calls the “most immediate cause of health 
service use”212 or “need” can refer to an interpretation based on the patient or physician’s 
perception or judgment of the value of intervention. Collectively, these environment and 
population characteristics influence the use of healthcare services, which Andersen describes 
as “health behavior” (or, more fittingly, healthcare behavior). In this manuscript, use of health 
services has been described as being represented by spending (e.g., spending in the year 
following hospitalization) or utilization (e.g., number of inpatient admissions in a given time 
period). Use of health services ultimately impacts outcomes and patients’ final health status.  
 
 38 
Application of Conceptual Framework to Studying Geographic Variation 
The conceptual framework can be applied to studying the effects of variation in Medicare 
spending on a myriad of outcome measures. Analyses can harness geographic variation in 
practice patterns (Healthcare System characteristics), such as measures of regional intensity 
at the EOL, as a source of possible instrumental variables to estimate causal effects while 
controlling for Predisposing Characteristics and Enabling Resources. The dashed line 
extending backward from Outcomes to Use of Health Services illustrates the possible 
endogeneity concern discussed previously (here depicted as a form of reverse causality). 
 
In Andersen’s model, hospital services received in response to more serious diseases and 
conditions would be predominantly explained by the categories Need and Predisposing 
Characteristics (e.g., baseline health status and demographics).210 Researchers at Dartmouth 
and others have often identified study populations on the basis of medical need by selecting 
subgroups of patients hospitalized with acute episodes of specific diseases (e.g., AMI, hip 
fracture, stroke, gastrointestinal bleeding) because these exhibit minimal variation in their 
hospitalization rates across regions, suggesting that patients with incident cases likely have 
similar severity of illness regardless of their geographic location.121 Predisposing 
Characteristics and Enabling Resources (e.g., wealth) are important control variables and 
represent demand-side factors discussed previously.  
 
The conceptual framework also provides an opportunity to analyze additional understudied 
determinants of spending and utilization. Much of the variation in spending across regions 
remains unexplained.36 For example, health behaviors and modifiable risk factors—smoking, 
obesity, alcohol consumption, and physical activity—rather than practice styles of varying 
intensity may be important causal factors explaining regional variation in utilization.22 In the 
conceptual model, health behaviors are a type of predisposing characteristic emanating from 
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beliefs and values concerning health and illnesses.213 In Chapter 3 (Aim 2), decomposition 
techniques are used to quantify the contribution of health behaviors and patient characteristics 
to explain regional variation in the spending and utilization (Use of Health Services). 
Implementation of this method requires using Dartmouth Atlas measures of regional treatment 
intensity to divide respondents into mutually exclusive groups of higher-versus-lower regional 
intensity (Healthcare System characteristics) based on where they live and then estimating 
separate regressions for each group. This decomposition offers a way to differentiate between 
differences in utilization that derive from observable differences in group Predisposing 
Characteristics (specifically, health behaviors and modifiable risk factors) versus differences 
owing to unexplained factors, which plausibly include provider practice patterns in how the 
groups are treated. 
 
DISCUSSION 
This review has emphasized the determinants and consequences of geographic variation in 
healthcare spending and utilization by bringing these diverse literatures together and adapting a 
well-known conceptual framework to describe how these demand-side and supply-side factors 
contribute to healthcare spending and outcomes. When viewed collectively, the body of 
evidence appraised herein suggests several important directions and considerations for future 
research. As identified in Part 1 of the review, health behaviors and modifiable risk factors as 
possible determinants of variation in spending have been understudied because data on 
smoking, alcohol consumption, diet, and physical activity or exercise are rarely collected in 
administrative datasets. Similarly, a hallmark of the literature on the consequences of 
geographic variation in spending has been its predominant use of administrative data, such as 
Medicare claims, and its focus on mortality and survival as the primary representations of health. 
Consequently, studies of non-mortality outcomes (capturing, health status, functioning, and 
health-related quality of life) are limited in number. Yet because much of health care aims to 
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improve health-related quality of life, and not solely mortality or survival, assessing the effects of 
spending on a comprehensive set of outcomes is an important direction for future studies. 
Conducting such studies requires datasets with broad geographic coverage that also collect 
data on such outcomes, a feature jointly offered by few datasets.  
 
In addition, more rigorous research designs can improve inference about whether additional 
healthcare spending is causally related to outcomes. While the majority of such studies 
examined in this manuscript used standard multiple regression approaches and were likely 
limited by omitted variable bias, there is a precedent in the health economics literature for using 
instrumental variables analysis—an approach that is adopted in Chapter 4 (Aim 3).  
Instrumental variables analysis can provide policymakers with more accurate information about 
the effects of healthcare spending on patient outcomes.  
 
This review also suggests possible challenges to anticipate when planning new studies. First, as 
has been demonstrated with mortality, measurable benefit from treatment intensity may wane 
with time,158 and this may be true for other outcomes as well, complicating the ability to detect 
an effect for outcomes measured long after the initial hospitalization. Second, the assessment of 
outcome measures should ideally be related to the level of analysis and the specification of 
spending measures. For example, it may be difficult to detect an effect of inpatient 
utilization/spending following an index hospitalization on long-term mortality due to confounding 
by other sources of utilization that occur between the time utilization is measured and mortality 
is assessed (e.g., outpatient and post-acute utilization). Such “history effects,” as noted in the 
lexicon of Shadish, Cook, and Campbell (2001),214 can be minimized through study design 
considerations. Region-level analyses might benefit from analyzing longer-term outcomes and 
aggregate spending whereas hospital-level studies might benefit from using shorter-term 
outcomes and inpatient spending, which are more tightly coupled with the effects of the hospital. 
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Third, studies examining outcomes other than mortality, such as health-related quality of life, 
face the problem of death as a competing risk. Truncation due to death is an important threat to 
validity, because survivors with observed outcomes are not a random sample of the study 
population. There are a variety of approaches for handling truncation due to death. One 
straightforward approach is to use composite outcomes that combine information about survival 
and the health-related quality of life measure.215 Alternatively, sensitivity analysis procedures 
formalized within a principal stratification framework can be used to draw inferences about 
survivor average causal effects.216 Principal stratification has several advantages over other 
approaches, such as selection models, because patient-reported outcomes are undefined when 
the outcomes are not observed.215,217 
 
Fourth, care must be taken when using comorbidities derived from claims data due to the risk of 
observational intensity bias. Nevertheless, confounding by severity of illness is a central 
challenge facing studies assessing the consequences of geographic variation. Concerns 
inherent in risk adjustment can be addressed by (1) identifying more homogenous disease-
specific subgroups; (2) considering the inclusion of additional health status characteristics 
derived directly from patients—such as smoking status, alcohol consumption, and body mass 
index—that are more likely to be free from observational intensity bias or variation in physician 
diagnostic practices; and (3) using instrumental variables estimation, which can mitigate biases 
from unmeasured confounders, as described previously. In its report, the IOM advocated for 
health status measures derived from claims data to be supplemented by behavioral and clinical 
data for Medicare and commercially insured beneficiaries.3  
 
In light of this discussion, this dissertation addresses important gaps in current knowledge about 
the determinants and consequences of geographic variation in spending for older Americans. 
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First, the dissertation will analyze a comprehensive set of outcome measures related to multiple 
dimensions of health and functioning—activities of daily living, pain, cognition, and depressive 
symptoms—that are essential to the quality of life of the aging population, but are understudied 
in the geographic variation literature. Second, this dissertation extends previous research by 
using econometric methods that facilitate causal inference for questions salient to policymakers. 
Regression decomposition techniques quantify the contribution of health behaviors, an 
understudied set of determinants of utilization, by explaining variation in spending and utilization 
across regions. Instrumental variables estimation is used to estimate causal effects of 
healthcare spending/utilization on outcomes, an improvement on existing observational 
research in this literature. These contributions are made possible by leveraging a novel 
dataset—the Health and Retirement Study (HRS) linked to Medicare claims—that combines 
broad geographic coverage with data on utilization (via the claims) and patient-reported health 
outcomes and behaviors (via the survey), rendering it ideally suited to the aims of this 
dissertation and for advancing an understanding of the determinants and consequences of 




Figure 2.1. Conceptual Model 
 
 




CHAPTER THREE (MANUSCRIPT #2) 
 
RELATIONSHIP BETWEEN GEOGRAPHIC VARIATION IN MEDICARE SPENDING 
AND BENEFICIARIES’ BEHAVIORAL RISK FACTORS 
 
by  






Importance: Perennial debate about the pronounced and persistent variation in Medicare 
spending across regions of the United States centers on whether variation is due to 
inefficiencies in providers’ practice patterns or to beneficiaries’ characteristics. In particular, little 
is known about how beneficiaries’ behavioral risk factors contribute to geographic variation in 
healthcare spending.  
Objective: To examine beneficiaries’ behavioral risk factors and their relationship to regional 
variation in Medicare spending.   
Design: Secondary analysis of data from the nationally representative Health and Retirement 
Study linked to Medicare claims and regional spending characteristics from The Dartmouth 
Atlas of Health Care. Regression-based decomposition analysis was used to assess the 
contributions of beneficiaries’ characteristics (sociodemographics, behavioral risk factors, and 
health status) to Medicare spending across higher- versus lower-spending regions. 
Setting: Hospital referral regions in the United States. 
Participants: Medicare beneficiaries, aged 65 or older, in fee-for-service Medicare in 2004. 
Exposures: Smoking status, alcohol consumption, body mass index, and physical activity. 
Main Outcomes and Measures: Medicare Part A and B spending for 2004-2006 (price-
adjusted, expressed in 2006 U.S. dollars). The percent of regional variation in spending 
explained by different beneficiary characteristics was calculated. 
Results: Among 8,476 Medicare beneficiaries, individual characteristics explained 17% of 
regional differences in price-adjusted Medicare spending. Behavioral risk factors collectively 
explained 7% of the $5,718 difference in spending between higher- and lower-spending regions.  
Conclusions: Although the majority of regional variation in Medicare spending was not 
explained by beneficiary characteristics, policies designed to mitigate behavioral risk factors 
among Medicare beneficiaries in higher-spending regions may provide an opportunity to 
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modestly reduce geographic variation in spending. Additional research is needed to better 





For decades, policymakers have been interested in longstanding variation in Medicare spending 
across regions of the United States.220 The perennial debate—centered on which factors 
contribute to this geographic variation—has been framed by divergent perspectives about the 
relative importance of beneficiary-versus-provider characteristics.35-37 While prior research has 
demonstrated that beneficiary characteristics such as health status account for a small-to-
moderate proportion of the variation in healthcare spending across regions,37,199 other important 
factors such as beneficiaries’ health behaviors and modifiable risk factors have not been 
adequately studied as possible drivers of regional variation in spending.18   
 
Behavioral risk factors, specifically smoking, alcohol consumption, obesity, and limited physical 
activity, are prevalent in the aging American population,14 vary geographically,15,16 and represent 
a major source of growth in healthcare spending in the preceding decades.17 Policymakers need 
better information about whether targeting the modifiable antecedent causes of disease—
beneficiaries’ lifestyle factors—could reduce spending in higher-spending regions.  
 
To address this gap, we linked Medicare beneficiaries’ self-reported data on health behaviors 
and modifiable risk factors from the Health and Retirement Study (HRS) to utilization data 
contained in Medicare claims. The objective of this study was to examine whether behavioral 
risk factors contribute to explaining the marked variation in Medicare spending across regions of 
the United States.  
 
METHODS 
Data Sources and Sample 
The primary source of data was the HRS, a large, nationally representative, prospective cohort 
study of older Americans that has been used in prior research to examine geographic variation 
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in Medicare spending.199,221-223 We linked survey measures of sociodemographic characteristics, 
behavioral risk factors, and health and functioning from the HRS to respondents’ Medicare 
claims. We studied respondents who participated in the 2004 wave of the HRS, in which, 86% 
of eligible respondents consented to release their Medicare claims for research purposes. 
 
Because we wanted to observe beneficiaries’ actual Medicare spending, we could only study 
those who were enrolled in traditional (fee-for-service) Medicare since claims data are not 
available for those who select a managed care plan through the Medicare Advantage option. In 
2004, Medicare Advantage enrollment was at an historic low nationally (13%) during the 1999-
2015 period (and approximately 17% among HRS-Medicare linked respondents in our 
sample).224 Use of 2004 as the base year served to reduce sample selection bias from those 
beneficiaries selecting into Medicare Advantage plans who might differ in health status, health 
behaviors, or in unmeasured ways.  
 
We restricted the study population to respondents who were 65 years or older (N = 10,393), 
enrolled in fee-for-service Medicare (N = 8,532) during 2004, and for whom employer-
sponsored insurance was not the primary payer (N = 8,476). To prevent reductions in sample 
size, we did not exclude respondents who switched to Medicare Advantage plans after 2004 or 
who did not have full enrollment in both Medicare Parts A and B during the study period. Instead, 
we included variables to model these coverage characteristics and conducted a sensitivity 
analysis to explore the effect of excluding these respondents.  
 
Behavioral Risk Factors 
We assessed respondents’ smoking status, alcohol consumption, body mass index (BMI), and 
physical activity because these are commonly studied behavioral risk factors and improvements 
to these factors could reduce healthcare costs and premature deaths from cardiovascular 
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disease, cancer, and other causes.225 Based on respondents’ HRS survey responses, we 
divided smoking status into three categories: nonsmoker, former smoker, or current smoker. 
Alcohol consumption was based on respondents’ use within a 3-month reference period. It was 
categorized using a quantity-frequency approach similar to that used in prior studies: abstainers 
(no alcohol use), light drinkers (1 to 3 drinks per week), moderate drinkers (4 to 7 drinks per 
week for women; 4 to 14 drinks per week for men), heavy drinkers (8 to 34 drinks per week for 
women; 15 to 34 drinks per week for men), and very heavy drinkers (≥35 drinks per week for 
both sexes).226 BMI was calculated using respondents’ self-reported height and weight and 
classified into the following categories based on standard Centers for Disease Control and 
Prevention (CDC) criteria: underweight (BMI below 18.5), normal weight (18.5 to 24.9), 
overweight (25.0 to 29.9), or obese (30 or above).227 We also assessed respondents’ physical 
activity—whether they engaged in light, moderate, and vigorous physical activity at least weekly 
(these categories were not mutually exclusive). Light physical activity included activities such as 
vacuuming and doing laundry and home repairs. Moderate exertion referred to activities such as 
gardening, walking at a moderate pace, and performing stretching exercises. Vigorous exertion 
included activities such as running or jogging, swimming, cycling, and gym workouts.  
 
Medicare Spending and Utilization 
Our primary outcome measure was total Medicare spending for these respondents over the 3-
year period from 2004 to 2006. This cumulative measure included spending for care in a variety 
of settings (inpatient, skilled nursing facilities, outpatient, physician office, home health, and 
hospice), as well as spending for durable medical equipment. For each year, we adjusted 
spending for regional differences in price using the ratio of price-standardized to price-
unstandardized Medicare Part A and B spending within respondents’ hospital referral regions. 
Hospital referral regions (HRR) are local markets wherein beneficiaries receive the 
preponderance of their health care.220 Price adjustment reduces the effects of the varying labor, 
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capital, and overhead costs encountered across regions and serves to more accurately reflect 
the quantity of care utilized.124 Total Medicare spending from 2004 to 2006 was expressed in 
2006 U.S. dollars based on the medical care component of the Consumer Price Index. As 
secondary outcome measures, we examined the number of inpatient admissions and outpatient 
or physician office visits incurred by respondents between 2004 and 2006.  
 
Regional Spending Level 
We divided respondents into mutually exclusive groups of higher- and lower-spending regions 
based on whether their HRR was in the top or bottom half, respectively, of the national 
distribution of price-adjusted Medicare Part A and B spending. These regional Medicare 
spending data were obtained from The Dartmouth Atlas of Health Care.19  
 
Statistical Analysis 
Our empirical analysis centered on determining how much of the observed variation in Medicare 
spending across U.S. regions could be explained by beneficiaries’ behavioral risk factors. To 
this end, we used a regression-based decomposition analysis originally developed by labor 
economists Blinder and Oaxaca to study wage gaps between men and women,228,229 and which 
has been applied in health policy and geographic variation research.230-232  We used this method 
to quantify how much of the difference in Medicare spending between higher- and lower-
spending regions could be explained by differences in beneficiaries’ observable characteristics 
(particularly, their behavioral risk factors) versus differences in the way that providers in those 
different regions would treat the same beneficiary.231,233,234   
 
We used multivariate regression models to examine the relationship between Medicare 
spending and beneficiaries’ behavioral risk factors. To model positively skewed Medicare 
spending, we estimated generalized linear models with a gamma distribution and log link.235,236 
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To model utilization outcomes—inpatient admissions and outpatient or physician office visits—
we fit generalized linear models with a negative binomial distribution and log link. Standard 
errors were clustered by region.237 To determine the contribution of behavioral risk factors (and 
other beneficiary characteristics) to explaining regional variation in spending, we compared the 
regression-adjusted Medicare spending for beneficiaries in lower-spending regions with the 
spending that would have been predicted if they had the distribution of sociodemographic 
characteristics, behavioral risk factors, health and functioning, and insurance coverage of 
beneficiaries in higher-spending regions.234,238 We then calculated the proportion of the regional 
difference in Medicare spending attributable to beneficiaries’ behavioral risk factors and other 
characteristics.  
 
In addition to behavioral risk factors, our regressions also accounted for the following 
characteristics that may vary across regions: sociodemographic characteristics (including age, 
sex, race/ethnicity, educational achievement, household wealth, poverty status, marital status, 
household size, and urban status), health and functional status (including self-rated health, 
proxy respondent status [as an indirect measure of health], death between 2004-2006, 
limitations in activities of daily living (ADLs) and instrumental activities of daily living (IADLs), 
and cognitive status), and insurance coverage (including whether respondents had any 
enrollment [at least 1 month] in a Medicare Advantage plan in 2005 or 2006, any discontinuous 
enrollment in both Medicare Parts A and B [at least 1 month] between 2004 and 2006, and 
supplementary private insurance). In the main analyses, we did not control for diseases or 
conditions in order to avoid introducing a bias associated with regional variation in physicians’ 
diagnostic practices and observational intensities.42  
 
We conducted numerous sensitivity analyses to assess the robustness of our results. First, we 
repeated our analyses using different outcome measures, including a longer 5-year interval 
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(spending and utilization between 2004 and 2008) and using 2006 as the base year (spending 
and utilization between 2006 and 2008) for HRS respondents who participated in the 2006 
survey wave. Second, we examined the effect of including disease and condition variables, 
which are plausibly associated with regional variation in diagnostic practices,42 similar to prior 
studies. Third, we repeated our analyses after correcting the BMI variable for possible self-
reporting bias.239  Fourth, we assessed the sensitivity of our results to alterations in the 
composition of the study sample by repeating our analyses after doing the following: excluding 
veterans (for whom the Department of Veterans Affairs may be the primary payer), excluding 
respondents who did not have continuous Part A and B coverage over the 3-year observation 
period, and excluding respondents who died after 2004. 
  
Fifth, to address the concern that respondents in higher- versus lower-spending regions may 
self-select differently into Medicare Advantage during the observation period, we compared 
characteristics of beneficiaries “lost” to Medicare Advantage to fee-for-service beneficiaries 
remaining in the sample. We examined whether beneficiaries using Medicare Advantage 
differed on baseline characteristics in higher- versus lower-spending regions. We also 
implemented selection models to correct for possible sample selection bias owing to Medicare 
Advantage enrollment. Lastly, we examined versions of the standard linear Blinder-Oaxaca 
decomposition.229 Details of all sensitivity analyses are provided in the Appendix. 
 
We used Stata 14.0 (StataCorp, College Station, Texas) for all analyses. Reported P values are 
two-sided; a P value of 0.05 or less designated statistical significance. This study was approved 




Characteristics of the Study Sample 
In 2004, 11,399 of 13,175 HRS respondents with linked Medicare claims (86.5%) were 
interviewed. Of these, we excluded 1,006 respondents who were under age 65, 1,861 who were 
enrolled in Medicare Advantage plans during 2004, and 56 who reported having primary health 
insurance coverage through an employer. The remaining sample included 8,476 beneficiaries. 
 
The mean age of all beneficiaries was 75.2 years; 58% were female, 21% were nonwhite, 10% 
were below the federal poverty threshold, and 69% lived in urban areas. Beneficiaries living in 
lower-spending hospital referral regions (median regional spending in 2004 was $6,680; range, 
$5,112 to $7,324) varied considerably on most of the observable characteristics from 
beneficiaries in higher-spending regions (median regional spending in 2004 was $7,986; range, 
$7,330 to $11,609) (Table 3.1). In particular, beneficiaries in higher-spending regions were more 
likely to be nonwhite, have lower educational achievement and wealth, and to live in urban 
areas. These beneficiaries were also more likely to abstain from drinking alcohol (64% versus 
58%; P<0.001) and were less likely to engage in weekly moderate or light physical activity (59% 
versus 63%; P<0.001, and 72% versus 76%; P<0.001, respectively). These same beneficiaries 
generally reported a lower health status and were less likely to have supplemental private 
insurance. Beneficiaries in higher- versus lower-spending regions did not differ in their likelihood 
of having any Medicare Advantage enrollment in 2005 or 2006. 
 
On average, total Medicare spending for beneficiaries between 2004 and 2006 was $27,759 
with 1.1 inpatient admissions, and 32.0 outpatient facility or physician office visits (Table 3.1). In 
unadjusted comparisons, beneficiaries in higher-spending regions had $5,545 higher average 
Medicare spending compared to beneficiaries in lower-spending regions (P<0.001).  
 
 54 
Factors Explaining Regional Variation in Spending and Utilization 
Figure 3.1 demonstrates the effects of sequentially controlling for additional sets of variables in 
the regression model on the difference in Medicare spending between higher- and lower-
spending regions. Based on the unadjusted model, which accounts only for regional differences 
in price, Medicare spending was 22% higher comparing higher- to lower-spending regions. The 
absolute difference in Medicare spending between higher- and lower-spending regions 
decreased by 25% and 30% when sociodemographic characteristics and then behavioral risk 
factors were added, respectively. 
 
Overall, beneficiary characteristics explained 17% of the regional differences in Medicare 
spending (Table 3.2). Among the observable characteristics, behavioral risk factors and health 
status were important contributors to the lower spending for beneficiaries in lower-spending 
regions, explaining 7% and 14%, respectively, of the $5,718 difference in predicted spending 
between beneficiaries in higher- and lower-spending regions. While these characteristics 
contributed toward increasing the difference in spending between higher-versus-lower-spending 
regions, other characteristics decreased the difference. For example, insurance coverage 
characteristics—specifically supplementary private insurance coverage, which beneficiaries in 
lower-spending regions were more likely to possess—reduced the regional difference in 
spending by 6%. Similar relationships were observed between beneficiary characteristics and 
inpatient admissions, whereas nearly all of the regional difference in outpatient and physician 
office visits was not explained by beneficiary characteristics.   
 
Figure 3.2 shows the predicted Medicare spending for beneficiaries in lower- and higher-
spending regions. If beneficiaries in lower-spending regions had the same distribution of 
characteristics (e.g., behavioral risk factors and health status factors) as beneficiaries in higher-
spending regions, their Medicare spending would be $956 higher; 83% of the regional difference 
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in Medicare spending cannot be attributed to differences in beneficiaries’ observable 
characteristics.  
 
Across most characteristics, beneficiaries in higher-spending regions incurred significantly 
higher Medicare spending between 2004 and 2006 than beneficiaries in lower-spending regions 
(Figure 3.3; Appendix Table S3.1). For example, beneficiaries in higher-spending regions who 
were overweight or former smokers had $8,024 (95% CI, $4,675 to 11,372) and $7,637 (95% CI, 
$3,937 to $11,337) higher spending, respectively, than beneficiaries who were overweight or 
former smokers in lower-spending regions. Models estimated separately for beneficiaries in 




Our results were robust across numerous sensitivity analyses that examined alternative 
outcome measures, added disease and condition variables, altered the composition of the study 
sample, corrected BMI for self-reporting bias, implemented versions of the standard linear 
Blinder-Oaxaca decomposition, and adjusted for selection into Medicare Advantage (Appendix 
Tables S3.4 and S3.5).   
 
DISCUSSION 
By using nationally representative survey data from the HRS linked to Medicare claims, we 
examined whether smoking, alcohol consumption, BMI, and physical activity contribute to 
geographic variation in Medicare spending and utilization. Our results demonstrated that these 
factors collectively explained 7% of the difference in spending between higher- and lower-
spending regions. While the majority of the difference in spending was not explained by 
beneficiary characteristics, improving the health behaviors of beneficiaries in higher-spending 
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regions presents an opportunity to modestly reduce geographic variation in spending while also 
improving the health of the Medicare population.  
 
This study contributes to the ongoing debate over the importance of beneficiaries’ 
characteristics as determinants of geographic variation in Medicare spending. In contrast to 
prior research, we included a broader set of characteristics, many previously unstudied; these 
included health behaviors and modifiable risk factors of smoking status, alcohol consumption, 
BMI, and physical activity, as well as household wealth, poverty status, household size, 
limitations in ADLs and IADLs, and cognitive status. By focusing on behavioral risk factors, we 
sought to isolate the importance of beneficiaries’ lifestyle characteristics that are potentially 
modifiable through interventions that promote healthy behaviors in patients or, alternatively, that 
train and incentivize physicians to help patients quit smoking, consume alcohol within 
acceptable ranges, maintain healthily diets and weights, and engage in appropriate physical 
activity.240 Public health research demonstrates the substantial opportunity to reduce morbidity, 
mortality, and healthcare costs through such lifestyle changes.241-244 
 
The findings of our study are consistent with prior research, which has shown that beneficiary 
characteristics explain only a moderate amount of geographic variation in Medicare spending. 
Two prior and related studies, using a different dataset and empirical approach, demonstrated 
that measures of blood pressure, diabetes, BMI, smoking history, and self-rated health 
explained 18% of the difference in spending between the highest- and lowest-spending 
regions,38 but adding over 10 additional health variables—among these, the presence and 
diagnosis of specific diseases, and whether beneficiaries died or had proxy respondents—could 
explain 29% of the regional difference in spending.37 However, our results differ from two 
notable and recent studies, which determined that patient characteristics account for the 
majority of regional variation in healthcare spending. The first implemented a modified version of 
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Medicare’s Hierarchical Condition Categories model—a risk adjustment model based on billing 
data—and found that population health explains between 75% and 85% of spending 
variations.39 The second study used the state as the unit of analysis (rather than the beneficiary), 
and found that 81% of state-level variation in Medicare spending could be explained by a limited 
set of aggregate demographic and health measures.245 The findings of both studies remain 
susceptible to important biases or methodological limitations,40-42,44,246 and contradict a diverse 
literature that emphasizes provider factors as key determinants of geographic variation in 
spending.94,96,199  In our study, the inclusion of respondent-reported diseases and conditions, 
plausibly associated with regional diagnostic practices, did not alter the percentage of variation 
explained.  
 
When viewed collectively with this prior research, our results reinforce the perspective that non-
beneficiary factors are likely to be important determinants of geographic variation in Medicare 
spending and point toward the role of payment reform and policies aimed at providers’ treatment 
patterns. Nevertheless, behavioral risk factors were an important and distinct contributor 
amongst the observable characteristics we studied, indicating that these factors should not be 
ignored when making regional comparisons of spending. While a 7% reduction in Medicare 
spending in higher-spending regions—such as through smoking cessation programs or 
interventions to increase physical activity—seems small in an absolute sense, it nonetheless 
represents approximately $70 million of potential savings based on Medicare expenditures in 
2013. Furthermore, policy interventions promoting healthy behaviors within the whole Medicare 
population may also be important for reducing across-the-board utilization through 
improvements in health, regardless of the effect these interventions have on geographic 
differences in spending.244,247-250 Unlike initiatives targeting provider practice patterns, efforts to 
improve beneficiaries’ health behaviors may also increase life expectancy and enhance quality 
of life.    
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Our findings also suggest that alternative policies focused on providers—such as those that 
would adjust provider reimbursements based on regional spending patterns—could unduly 
reward or penalize certain regions if beneficiary characteristics are not adequately accounted for. 
This study highlights the utility of national surveys such as the HRS for investigating the 
relevance of beneficiary characteristics—characteristics that are rarely available in 
administrative datasets alone—and for demonstrating the potential for better risk adjustment in 
the future if health behaviors are collected through electronic health records. Nevertheless, 
given the relative importance of non-beneficiary characteristics, future research can elucidate 
how provider factors, such as physicians’ training, local treatment norms, and practice patterns, 
contribute to geographic variation in Medicare spending. 
 
This study has several limitations. First, because our initial study population was selected based 
on enrollment in traditional (fee-for-service) Medicare, our results may not generalize to 
Medicare Advantage or privately insured beneficiaries. To reduce bias owing to the exclusion of 
Medicare Advantage beneficiaries (whose spending and utilization data is not released to 
researchers), we used 2004 as the base year in our analyses because traditional Medicare 
accounted for 87% of total Medicare enrollment in 2004—higher than in subsequent years.224 
Sensitivity analyses demonstrated that the observable characteristics of respondents leaving 
traditional Medicare during the study period were largely similar in higher- versus lower-
spending regions (Appendix Table S4.6), increasing the likelihood that unmeasured aspects of 
health status were also similar.251 Explicit adjustments for selection into Medicare Advantage did 
not substantively alter our results. 
 
Second, although the difference in spending between higher- and lower-spending regions that 
was not explained by beneficiary characteristics can be considered analogous to a “treatment 
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effect” of regional practice patterns on beneficiary-level spending,252 we do not ascribe a causal 
interpretation to this relationship. Some of the observable variables included in our analyses are 
unlikely to be pre-treatment variables: for example, a beneficiary’s current health and functional 
status may be affected by healthcare use in prior years.253 In addition, although we included a 
comprehensive set of plausible confounders consistent with prior research and theoretical 
models of health service utilization,210 the absence of some relevant confounders—particularly 
those related to health status and severity of illness—from our models may be an extant source 
of bias. However, the results of sensitivity analyses that included additional disease variables 
were consistent with our main findings.  
 
Finally, information on behavioral risk factors was obtained by self report and may be subject to 
measurement error, particularly underreporting of socially undesirable behaviors, misreporting 
of height and weight, or difficulty recalling the extent of certain behaviors.88,239,254-256 On balance, 
we do not expect measurement error to differ in higher- versus lower-spending regions, 
reducing the possibility that measurement error biased the results of the decomposition 
analyses. Nevertheless, we implemented a published method to correct BMI for self-reported 
height and weight,239 which did not change our results. BMI derived from self-reported height 
and weight was highly correlated (95%) with BMI based on measured height and weight for a 
random subsample of respondents for whom HRS collected both sets of measures. HRS 
measures of behavioral risk factors and their prevalence are also concordant with other national 
studies such as the National Health Interview Survey and National Health and Nutrition 
Examination Survey.257  
 
Despite these limitations, our study provides evidence of the role of smoking status, alcohol 
consumption, BMI, and physical activity as determinants of geographic variation in Medicare 
spending. Comparing Medicare beneficiaries in higher- and lower-spending regions who 
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participated in a large, nationally representative, and longitudinal study, we found that such 
health behaviors and modifiable risk factors explained 7% of the regional variation in Medicare 
spending. Health promotion programs targeting older Americans may present an opportunity to 
modestly reduce geographic variation in healthcare spending, but additional research is needed 





Figure 3.1. Differences in Medicare Spending Between Lower-Spending Regions and 
Higher-Spending Regions, Based on Five Models 
 
Medicare spending per beneficiary between 2004 and 2006 is price-adjusted and expressed in 
2006 U.S. dollars. The coefficient is the average marginal effect from a generalized linear model 
of a dichotomous dummy variable denoting higher-versus-lower spending hospital referral 
regions. The first model included only the dummy variable for regional spending levels, 
representing the difference in price-adjusted Medicare spending between higher- and lower-
spending regions. The second model added sociodemographic variables (age, sex, 
race/ethnicity, educational achievement, household wealth, poverty status, marital status, 
household size, and urban status); the third model added the behavioral risk factor variables 
(smoking status, alcohol consumption, body mass index, and physical activity); the fourth model 
added health and functional status variables (self-rated health status, limitations in activities of 
daily living and instrumental activities of daily living, cognitive status, proxy respondent status 
[as an indirect measure of health], and death between 2002-2006); the fifth model added 
insurance variables (indicators for Medicare Advantage use in 2005 or 2006, discontinuous full 
Part A and B enrollment between 2004 and 2006, and supplementary private insurance).  
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Figure 3.2. Total Regression-Adjusted Medicare Spending Comparing Higher- and Lower- 
Spending Regions 
 
Average predicted Medicare spending is based on average marginal effects from a generalized 
linear model that adjusts for sociodemographic characteristics, behavioral risk factors, health 
and functional status characteristics, and insurance coverage. Regional spending level is based 
on data reported in The Dartmouth Atlas of Health Care and refers to total nondrug Part A and B 
spending in 2004, measured at the hospital referral region (HRR) level. “Lower” refers to HRRs 
below the median (median, $6,680; range, $5,112 to $7,324) and “higher” refers to HRRs above 
the median (median, $7,986; range, $7,330 to $11,609).   
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Figure 3.3. Differences in Regression-Adjusted Medicare Spending Between Higher- and 
Lower- Spending Regions for Selected Variables 
 
Abbreviations: BMI—body mass index 
Predicted Medicare spending is based on average marginal effects from a generalized linear 
model that adjusts for sociodemographic characteristics, behavioral risk factors, health and 
functional status characteristics, and insurance coverage. For each variable, the difference (and 
95% confidence interval) is calculated as the average predicted spending for beneficiaries in 
lower-spending regions subtracted from the average predicted spending for beneficiaries in 




Table 3.1. Characteristics of Beneficiaries by Hospital Referral Region (HRR) Spending Level, 2004  
  
Regional Spending Levela 
  Variable Total Lower Higher Difference P Value 
 
(N = 8476) (N = 4378) (N = 4098) 
  Spending and utilizationb 
     Medicare spending per beneficiary, mean (SD) 27759 (40311) 25078 (36005) 30623 (44279) 5545 <0.001 
Inpatient admissions per beneficiary, mean (SD) 1.1 (1.8) 1.0 (1.7) 1.2 (1.9) 0.2 <0.001 
Outpatient facility and physician office visits, mean (SD) 32.0 (27.9) 31.4 (27.5) 32.7 (28.2) 1.3 0.027 
Sociodemographic characteristics 
     Age, mean (SD) 75.2 (7.7) 75.0 (7.6) 75.5 (7.8) 0.4 0.009 
Female (%) 57.6 56.7 58.5 1.9 0.08 
Race/ethnicity (%) 
        White 79.1 81.5 76.5 -5.0 <0.001 
   Black 12.9 12.2 13.7 1.5 0.04 
   Hispanic 6.4 4.5 8.3 3.8 <0.001 
   Other 1.7 1.8 1.5 -0.3 0.25 
Educational achievement (%) 
        Less than high school 28.6 25.1 32.2 7.1 <0.001 
   Completed high school 36.9 36.8 37.1 0.3 0.75 
   More than high school 34.5 38.1 30.7 -7.5 <0.001 
Household wealth (%)c 
        Quintile 1 20.1 18.3 22.0 3.7 <0.001 
   Quintile 2 19.1 17.3 21.0 3.7 <0.001 
   Quintile 3 19.7 19.5 19.9 0.4 0.64 
   Quintile 4 19.8 21.3 18.3 -3.0 0.001 
   Quintile 5 21.3 23.7 18.8 -4.8 <0.001 
Below the federal poverty threshold (%) 10.3 8.7 12.0 3.3 <0.001 
Married (%) 55.7 57.1 54.3 -2.8 0.009 
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Household size, mean (SD) 2.0 (1.0) 1.9 (0.9) 2.0 (1.0) 0.0 0.05 
Urban (%) 68.9 66.1 71.8 5.7 <0.001 
Behavioral risk factors 
     Smoking status (%)      
   Nonsmoker 43.5 43.7 43.2 -0.5 0.67 
   Former smoker 47.1 47.6 46.6 -1.0 0.36 
   Current smoker 9.5 8.8 10.2 1.5 0.02 
Alcohol consumption (%)      
   Abstainers 60.6 57.7 63.7 6.0 <0.001 
   Light drinkers 23.9 26.0 21.8 -4.2 <0.001 
   Moderate drinkers 11.2 12.0 10.4 -1.6 0.02 
   Heavy drinkersd 4.2 4.4 4.1 -0.2 0.62 
Body mass index (BMI) category (%) 
        Underweight 3.0 2.8 3.3 0.4 0.27 
   Normal weight 37.6 37.5 37.8 0.4 0.73 
   Overweight 37.2 37.3 37.0 -0.3 0.77 
   Obese 22.1 22.3 21.9 -0.5 0.60 
Physical activity (weekly)      
Light exercise (%) 74.0 75.7 72.2 -3.4 <0.001 
Moderate exercise (%) 60.9 62.7 58.9 -3.8 <0.001 
Vigorous exercise (%) 24.5 25.0 23.9 -1.1 0.24 
Health and functional status 
     Self-rated health (%) 
        Excellent 8.1 8.9 7.3 -1.6 0.006 
   Very good 25.1 27.7 22.2 -5.5 <0.001 
   Good 32.3 31.7 32.9 1.2 0.241 
   Fair 23.3 21.7 24.9 3.2 <0.001 
   Poor 11.3 10.0 12.7 2.8 <0.001 
ADL limitations, mean (SD) 0.5 (1.2) 0.5 (1.1) 0.5 (1.2) 0.1 0.01 
IADL limitations, mean (SD) 0.5 (1.2) 0.5 (1.2) 0.5 (1.2) 0.1 0.04 
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Cognitive functioning (%) 
        Normal cognition 67.0 68.9 65.1 -3.8 <0.001 
   Cognitive impairment without dementia 21.7 20.6 22.9 2.3 0.009 
   Dementia 11.3 10.6 12.1 1.5 0.03 
Proxy respondent (%) 10.4 9.5 11.5 2.0 0.002 
Death in 2004-2006 (%) 12.9 12.9 13.0 0.1 0.92 
Insurance coverage 
     Medicare Advantage use in 2005 or 2006 (%) 8.1 8.0 8.2 0.2 0.76 
Discontinuous full Part A and B enrollment, 2004-2006 
(%) 18.1 18.2 17.9 -0.3 0.73 
Supplementary private insurance (%) 68.3 70.8 65.7 -5.1 <0.001 
Abbreviations: ADL, activity of daily living; IADL, instrumental activity of daily living. 
a Regional spending level is based on data reported in The Dartmouth Atlas of Health Care and refers to total nondrug Part A and B spending in 
2004, measured at the hospital referral region (HRR) level. Beneficiaries were divided into two mutually exclusive categories of higher- versus 
lower-regional spending on the basis of the spending in their HRR in 2004: HRRs below the median designate lower-spending regions (median, 
$6,680; range, $5,112 to $7,324) and HRRs above the median designate higher-spending regions (median, $7,986; range, $7,330 to $11,609). 
Percentages may not add up exactly to 100 due to rounding. 
b Spending and utilization outcomes are cumulative over the 2004-2006 period. Medicare spending includes total nondrug Part A and B 
reimbursements as well as the amount contributed by beneficiaries; spending was adjusted for cross-sectional differences in prices and is 
expressed in 2006 U.S. dollars based on the medical care component of the Consumer Price Index. 
c Respondents’ total household wealth (excluding individual retirement accounts) was measured in quintiles based on the full wealth distribution of 
respondents in the corresponding HRS survey wave. 




Table 3.2. Decomposition of Differences in Medicare Spending and Utilization by Regional Spending Levela 







Difference between higher- and lower-spending regionsb $5,718 0.19 1.31 
Percentage explained       
Difference attributable to beneficiary characteristics, % 17 24 1 
Difference not attributable to beneficiary characteristics, % 83 76 99 
Difference attributable to, %       
Sociodemographic characteristicsc -1 -1 -22 
Behavioral risk factorsd 7 11 -6 
Health statuse 14 18 56 
Functional statusf 3 1 -4 
Cognitive status -1 1 -8 
Insuranceg -6 -6 -16 
a Spending and utilization outcomes are cumulative over the 2004-2006 period. Medicare spending includes total nondrug Part A 
and B reimbursements as well as the amount contributed by beneficiaries. Positive percentages indicate that the variable set 
contributes toward increasing the difference in spending or utilization between higher- and lower-spending regions whereas 
negative percentages indicate that the variable set decreases the difference. Percentages may not add up exactly to 100 due to 
rounding. 
b Differences are based on average predicted outcomes from generalized linear models used in the decomposition. Regional 
spending level is based on data reported in The Dartmouth Atlas of Health Care and refers to total nondrug Part A and B spending 
in 2004, measured at the hospital referral region (HRR) level. Beneficiaries were divided into two mutually exclusive categories of 
higher- versus lower-regional spending on the basis of the spending in their HRR in 2004: HRRs below the median designate lower-
spending regions (median, $6,680; range, $5,112 to $7,324) and HRRs above the median designate higher-spending regions 
(median, $7,986; range, $7,330 to $11,609). 
c Sociodemographic characteristics include age, sex, race/ethnicity, educational achievement, household wealth, poverty status, 
marital status, household size, and urban status. 
d Behavioral risk factors include smoking status, alcohol consumption, body mass index, and physical activity.  
e Health status includes self-rated health, proxy respondent status (as an indirect measure of health), and death between 2004-
2006. 
f Functional status includes limitations in activities of daily living and instrumental activities of daily living. 
g Insurance includes indicators for Medicare Advantage use in 2005 or 2006, discontinuous full Part A and B enrollment between 
2004 and 2006, and supplementary private insurance.  
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APPENDIX 
Table S3.1. Predicted Spending for Beneficiaries’ Behavioral Risk Factors and Health Associated with Regional 
Spending Levels 
 
Predicted Spending, $ (95% CI)a 
 Variable Lower Spending Regions Higher Spending Regions Differenceb P Value 
Smoking status     
     Never smoker 23899 (22201 to 25597) 28565 (26267 to 30863) 4666 (1809 to 7523) 0.00 
     Former smoker 28581 (26591 to 30572) 36218 (33099 to 39337) 7637 (3937 to 11337) 0.00 
     Current smoker 22460 (19420 to 25500) 24740 (21016 to 28464) 2280 (-2527 to 7088) 0.35 
Alcohol consumption     
     Abstainer 30069 (27896 to 32243) 36573 (33812 to 39334) 6504 (2989 to 10018) 0.00 
     Light drinker 21260 (19142 to 23378) 23986 (21821 to 26150) 2725 (-303 to 5754) 0.08 
     Moderate drinker 20652 (17061 to 24242) 22485 (19623 to 25346) 1833 (-2758 to 6424) 0.43 
     Heavy drinker 16788 (12935 to 20640) 21646 (15181 to 28111) 4858 (-2668 to 12384) 0.21 
     Very heavy drinker 12984 (2020 to 23949) 27617 (6754 to 48480) 14633 (-8935 to 38201) 0.22 
Body mass index     
     Underweight 38726 (24857 to 52595) 44529 (35261 to 53798) 5803 (-10878 to 22485) 0.50 
     Normal 27393 (24869 to 29917) 31613 (28961 to 34265) 4220 (558 to 7881) 0.02 
     Overweight 22238 (20636 to 23840) 30262 (27321 to 33202) 8024 (4675 to 11372) 0.00 
     Obese 28414 (25503 to 31324) 32541 (28714 to 36369) 4128 (-681 to 8936) 0.09 
Light exercise     
     Less than weekly 44991 (41242 to 48741) 53240 (47995 to 58486) 8249 (1801 to 14697) 0.01 
     At least weekly 20086 (19024 to 21147) 23721 (22094 to 25347) 3635 (1693 to 5577) 0.00 
Moderate exercise     
     Less than weekly 38455 (35565 to 41345) 46454 (42466 to 50442) 7999 (3073 to 12924) 0.00 
     At least weekly 18777 (17721 to 19833) 21694 (20331 to 23056) 2917 (1193 to 4641) 0.00 
Vigorous exercise     
     Less than weekly 29282 (27466 to 31098) 35727 (33240 to 38213) 6445 (3366 to 9524) 0.00 
     At least weekly 16340 (14685 to 17995) 19232 (17416 to 21049) 2892 (435 to 5350) 0.02 
Self-rated health status     
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     Excellent health 12177 (10209 to 14145) 13591 (10812 to 16369) 1414 (-1991 to 4819) 0.42 
     Very good health 14886 (13475 to 16296) 17688 (15833 to 19543) 2802 (472 to 5133) 0.02 
     Good health 22328 (20391 to 24264) 25513 (23755 to 27271) 3185 (570 to 5800) 0.02 
     Fair health 39094 (36016 to 42171) 40703 (36158 to 45247) 1609 (-3879 to 7097) 0.57 
     Poor health 53668 (47554 to 59783) 66549 (58733 to 74365) 12881 (2957 to 22804) 0.01 
Cognitive status     
     Normal cognition 21689 (20402 to 22976) 24683 (23018 to 26348) 2994 (890 to 5098) 0.01 
     Cognitive impairment 31511 (28656 to 34367) 39413 (34943 to 43883) 7902 (2598 to 13206) 0.00 
     Dementia 45122 (38601 to 51643) 56737 (49883 to 63591) 11616 (2155 to 21076) 0.02 
No proxy 24360 (23046 to 25674) 28979 (26953 to 31005) 4619 (2204 to 7034) 0.00 
Proxy respondent 42893 (36076 to 49709) 54049 (47764 to 60335) 11156 (1884 to 20429) 0.02 
Survived 20150 (19113 to 21187) 24856 (23029 to 26682) 4706 (2606 to 6806) 0.00 
Death 2004-2006 66781 (59662 to 73901) 79522 (71048 to 87995) 12740 (1673 to 23808) 0.02 
a Predicted Medicare spending is based on average marginal effects from a generalized linear model that adjusts for sociodemographic 
characteristics, behavioral risk factors, health and functional status characteristics, and insurance coverage.  
b For each variable, the difference (and 95% confidence interval) is calculated as the average predicted spending for beneficiaries in lower-










Outpatient Facility and 
Physician Office Visits, 
Coefficient (SE) 
Age 70 to 74 0.15 (0.05) ** 0.23 (0.08) ** 0.027 (0.04) 
Age 75 to 79 0.27 (0.06) *** 0.37 (0.10) *** 0.16 (0.04) *** 
Age 80 to 84 0.22 (0.08) ** 0.37 (0.09) *** 0.16 (0.05) ** 
Age 85 to 89 0.22 (0.07) ** 0.39 (0.09) *** 0.15 (0.05) ** 
Age 90 and over 0.032 (0.1)  0.23 (0.1)  -0.092 (0.07) 
Female -0.034 (0.06)  -0.040 (0.06)  0.16 (0.03) *** 
African American -0.033 (0.08)  0.017 (0.09)  -0.089 (0.05)  
Hispanic -0.15 (0.1)  -0.28 (0.1) * -0.13 (0.09)  
Other race -0.11 (0.2)  -0.17 (0.2)  -0.092 (0.1)  
Less than high school 0.048 (0.07)  0.11 (0.08)  -0.0043 (0.04)  
More than high school 0.093 (0.06)  0.14 (0.06) * 0.074 (0.04)  
Wealth quintile 1 0.12 (0.06)  0.058 (0.08)  0.10 (0.05)  
Wealth quintile 2 -0.065 (0.06)  -0.089 (0.09)  -0.041 (0.04)  
Wealth quintile 4 -0.078 (0.07)  -0.12 (0.08)  0.0097 (0.05)  
Wealth quintile 5 -0.028 (0.06)  -0.14 (0.07) * 0.039 (0.05)  
Below poverty threshold -0.12 (0.08)  -0.18 (0.08) * 0.092 (0.06)  
Married -0.10 (0.06)  -0.098 (0.06)  0.058 (0.04)  
Household size 0.012 (0.03)  0.011 (0.03)  -0.0026 (0.02)  
Urban 0.0051 (0.05)  -0.060 (0.06)  -0.058 (0.06) 
BMI Underweight -0.017 (0.2)  -0.15 (0.2)  -0.24 (0.09) ** 
BMI Overweight -0.052 (0.05)  -0.079 (0.05)  0.052 (0.03)  
BMI Obese 0.11 (0.05) * 0.057 (0.06)  0.080 (0.03) * 
Light drinker -0.080 (0.06)  -0.17 (0.06) ** 0.023 (0.03)  
Moderate drinker -0.077 (0.10)  -0.13 (0.10)  0.016 (0.05)  







Very heavy drinker -0.57 (0.4)  -1.28 (0.6) * -0.73 (0.2) ** 
Former smoker 0.12 (0.04) ** 0.057 (0.05)  0.049 (0.03)  
Current smoker -0.022 (0.07)  -0.064 (0.09)  -0.25 (0.06) *** 
Weekly vigorous exercise -0.053 (0.07)  -0.16 (0.08) * -0.0018 (0.04)  
Weekly moderate exercise -0.14 (0.05) ** -0.13 (0.05) * -0.059 (0.03)  
Weekly light exercise -0.24 (0.06) *** -0.23 (0.07) *** -0.057 (0.04)  
Excellent health -0.87 (0.1) *** -0.97 (0.1) *** -0.67 (0.07) *** 
Very good health -0.72 (0.07) *** -0.85 (0.10) *** -0.51 (0.05) *** 
Good health -0.43 (0.07) *** -0.49 (0.08) *** -0.34 (0.05) *** 
Fair health -0.11 (0.06)  -0.17 (0.08) * -0.10 (0.05) * 
ADL limitations 0.049 (0.03)  0.050 (0.03)  -0.026 (0.02)  
IADL limitations 0.055 (0.03)  -0.022 (0.03)  0.0035 (0.02)  
Cognitive impairment without dementia -0.0034 (0.05)  0.12 (0.05) * -0.044 (0.03)  
Dementia -0.18 (0.08) * -0.056 (0.10)  -0.15 (0.06) * 
Proxy respondent -0.15 (0.09)  -0.18 (0.1)  -0.24 (0.07) *** 
Death 2004-06 1.27 (0.1) *** 1.16 (0.1) *** 0.40 (0.10) *** 
Any Medicare Advantage use in 2005-06 -0.41 (0.09) *** -0.39 (0.1) *** -0.34 (0.06) *** 
Discontinuous full Part A and B enrollment, 2004-06 -0.71 (0.1) *** -0.47 (0.1) *** -0.72 (0.09) *** 
Supplemental private insurance 0.22 (0.05) *** 0.21 (0.07) ** 0.14 (0.04) *** 
Abbreviations: BMI, body mass index; ADL, activity of daily living; IADL, instrumental activity of daily living. 
a The model for spending was estimated using a generalized linear model (GLM) with a log link and gamma distribution; the models for utilization 
outcomes used a negative binomial distribution. Spending and utilization outcomes are cumulative over the 2004-2006 period. Medicare spending 
includes total nondrug Part A and B reimbursements as well as the amount contributed by beneficiaries.  Standard errors (SEs) were clustered on 
hospital referral regions. 
* for p<.05; ** for p<.01; and *** for p<.001. N = 4233. 
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Outpatient Facility and 
Physician Office Visits, 
Coefficient (SE) 
Age 70 to 74 0.090 (0.05)  0.077 (0.07)  0.076 (0.04)  
Age 75 to 79 0.24 (0.06) *** 0.28 (0.07) *** 0.098 (0.04) * 
Age 80 to 84 0.27 (0.07) *** 0.30 (0.08) *** 0.12 (0.05) * 
Age 85 to 89 0.16 (0.08)  0.27 (0.09) ** -0.021 (0.05)  
Age 90 and over 0.068 (0.08)  0.20 (0.10) * -0.11 (0.06)  
Female -0.12 (0.05) * -0.14 (0.07) * 0.14 (0.03) *** 
African American 0.057 (0.07)  -0.038 (0.08)  -0.019 (0.05)  
Hispanic 0.12 (0.1)  -0.23 (0.07) ** 0.11 (0.06)  
Other race 0.0027 (0.2)  0.027 (0.2)  -0.23 (0.1)  
Less than high school 0.0084 (0.05)  0.014 (0.06)  -0.023 (0.04)  
More than high school -0.0030 (0.05)  -0.079 (0.06)  0.00019 (0.03)  
Wealth quintile 1 -0.042 (0.07)  -0.10 (0.08)  0.020 (0.05)  
Wealth quintile 2 -0.065 (0.06)  -0.099 (0.06)  -0.087 (0.04) * 
Wealth quintile 4 -0.057 (0.06)  -0.15 (0.09)  -0.011 (0.04)  
Wealth quintile 5 0.077 (0.06)  -0.059 (0.08)  0.097 (0.04) * 
Below poverty threshold 0.15 (0.06) * 0.026 (0.08)  0.099 (0.05)  
Married -0.078 (0.06)  -0.14 (0.07) * 0.085 (0.04) * 
Household size -0.0087 (0.02)  0.036 (0.02)  -0.030 (0.01) * 
Urban 0.13 (0.06) * 0.016 (0.07)  0.031 (0.04)  
BMI Underweight -0.12 (0.1)  -0.015 (0.2)  -0.22 (0.08) ** 
BMI Overweight 0.064 (0.06)  0.090 (0.06)  0.026 (0.03)  
BMI Obese 0.10 (0.07)  0.090 (0.07)  0.097 (0.04) * 
Light drinker -0.13 (0.05) ** -0.13 (0.05) ** -0.028 (0.03)  
Moderate drinker -0.099 (0.07)  -0.23 (0.08) ** -0.030 (0.05)  
Heavy drinker -0.13 (0.1)  -0.22 (0.1)  -0.13 (0.08)  
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Very heavy drinker -0.12 (0.3)  -0.0074 (0.4)  -0.033 (0.2)  
Former smoker 0.18 (0.04) *** 0.22 (0.05) *** 0.068 (0.03) * 
Current smoker -0.097 (0.08)  0.011 (0.09)  -0.20 (0.04) *** 
Weekly vigorous exercise -0.076 (0.06)  -0.14 (0.07)  -0.039 (0.03)  
Weekly moderate exercise -0.20 (0.05) *** -0.18 (0.06) ** -0.086 (0.03) * 
Weekly light exercise -0.16 (0.06) * -0.19 (0.06) ** -0.052 (0.04)  
Excellent health -0.84 (0.1) *** -0.87 (0.2) *** -0.78 (0.1) *** 
Very good health -0.66 (0.08) *** -0.81 (0.08) *** -0.49 (0.07) *** 
Good health -0.41 (0.07) *** -0.50 (0.07) *** -0.29 (0.06) *** 
Fair health -0.15 (0.07) * -0.30 (0.07) *** -0.096 (0.05)  
ADL limitations 0.098 (0.02) *** 0.023 (0.02)  0.013 (0.02)  
IADL limitations 0.024 (0.03)  0.069 (0.03) * -0.051 (0.02) * 
Cognitive impairment without dementia 0.095 (0.05)  0.15 (0.07) * -0.053 (0.03)  
Dementia -0.036 (0.09)  -0.066 (0.10)  -0.11 (0.07)  
Proxy respondent -0.19 (0.07) ** -0.20 (0.08) * -0.15 (0.04) *** 
Death 2004-06 1.29 (0.1) *** 0.99 (0.1) *** 0.52 (0.1) *** 
Any Medicare Advantage use in 2005-06 -0.30 (0.09) ** -0.14 (0.09)  -0.27 (0.06) *** 
Discontinuous full Part A and B enrollment, 2004-06 -0.75 (0.1) *** -0.45 (0.1) *** -0.90 (0.1) *** 
Supplemental private insurance 0.093 (0.05)  0.045 (0.06)  0.15 (0.04) *** 
Abbreviations: BMI, body mass index; ADL, activity of daily living; IADL, instrumental activity of daily living. 
a The model for spending was estimated using a generalized linear model (GLM) with a log link and gamma distribution; the models for utilization 
outcomes used a negative binomial distribution. Spending and utilization outcomes are cumulative over the 2004-2006 period. Medicare spending 
includes total nondrug Part A and B reimbursements as well as the amount contributed by beneficiaries.  Standard errors (SEs) were clustered on 
hospital referral regions. 






The following sensitivity analyses are presented in Appendix Tables S3.4 and S3.5. Sensitivity 
analyses A through H implemented the decomposition based on generalized linear models, as 
used in the main analysis. To assess the robustness of our results, we: 
A. Examined 5-year Medicare spending beginning in 2004 (rather than 3 as in main 
analysis)  
B. Used 2006 as a base year (instead of 2004), and examined 3-year Medicare spending 
through 2008 
C. Used price-unadjusted measure of Medicare spending 
D. Included disease/condition variables generally believed to be associated with regional 
variation in diagnostic practices as additional set of independent variables 
E. Excluded veterans 
F. Excluded respondents who did not have continuous Part A and B enrollment over the 
observation period  
G. Excluded respondents who died after the base year 
H. Corrected body mass index for respondent self-report using the Cawley method 
described in the main text  
I. Implemented the standard Blinder-Oaxaca decomposition (Medicare spending 
measured in dollars)  
J. Implemented the standard Blinder-Oaxaca decomposition (Medicare spending 
measured in log dollars)  







Table S3.4. Decomposition of Differences in Medicare Spending by Regional Spending Level, Sensitivity Analyses A 
through Fa 
  Main A B C D E F 
Difference between higher- and lower-spending regions, $b 5,718 11,556 8,076 5,820 5,664 5,370 5,577 
Percentage explained        
    Difference attributable to beneficiary characteristics, % 17 12 16 18 16 17 20 
    Difference not attributable to beneficiary characteristics, % 83 88 84 82 84 83 80 
Difference attributable to, %        
    Sociodemographic characteristicsc -1 -1 -4 1 -1 1 -3 
    Behavioral risk factorsd 7 4 5 7 7 8 8 
    Health statuse 14 14 17 14 10 12 16 
    Functional statusf 3 1 2 3 3 3 3 
    Cognitive status -1 -1 1 -1 -1 -2 0 
    Insuranceg -6 -5 -5 -6 -6 -4 -4 
    Diseases/conditionsh -- -- -- -- 5 -- -- 
a Medicare spending includes total nondrug Part A and B reimbursements as well as the amount contributed by beneficiaries. Positive 
percentages indicate that the variable set contributes toward increasing the difference in spending between higher- and lower-spending 
regions whereas negative percentages indicate that the variable set decreases the difference. Percentages may not add up exactly to 100 
due to rounding. 
b Differences are based on average predicted outcomes from generalized linear models used in the decomposition. Regional spending 
level is based on data reported in The Dartmouth Atlas of Health Care and refers to total nondrug Part A and B spending in 2004, 
measured at the hospital referral region (HRR) level. Beneficiaries were divided into two mutually exclusive categories of higher- versus 
lower-regional spending on the basis of the spending in their HRR in 2004: HRRs below the median designate lower-spending regions 
(median, $6,680; range, $5,112 to $7,324) and HRRs above the median designate higher-spending regions (median, $7,986; range, 
$7,330 to $11,609). 
c Sociodemographic characteristics include age, sex, race/ethnicity, educational achievement, household wealth, poverty status, marital 
status, household size, and urban status. 
d Behavioral risk factors include smoking status, alcohol consumption, body mass index, and physical activity.  
e Health status includes self-rated health, proxy respondent status (as an indirect measure of health), and death between 2004-2006. 
f Functional status includes limitations in activities of daily living and instrumental activities of daily living. 
g Insurance includes indicators for Medicare Advantage use in 2005 or 2006, discontinuous full Part A and B enrollment between 2004 and 
2006, and supplementary private insurance. 
h Diseases/conditions includes a variable that sums the number of diseases as well as indicators for high blood pressure, diabetes, cancer, 
lung disease, heart disease, stroke, psychiatric condition, and arthritis.  
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Table S3.5. Decomposition of Differences in Medicare Spending by Regional Spending Level, Sensitivity Analyses G 
through Ka 
  Main G H I J K 
Difference between higher- and lower-spending regions, $b 5,718 5,077 5,681 5,528 0.25 8,511 
Percentage explained       
    Difference attributable to beneficiary characteristics, % 17 25 18 17 13 16 
    Difference not attributable to beneficiary characteristics, % 83 75 82 83 87 84 
Difference attributable to, %       
    Sociodemographic characteristicsc -1 -2 -1 -3 -6 3 
    Behavioral risk factorsd 7 9 8 7 4 4 
    Health statuse 14 19 15 16 22 9 
    Functional statusf 3 4 4 4 2 3 
    Cognitive status -1 -1 -1 -2 1 -1 
    Insuranceg -6 -4 -6 -5 -10 -2 
a Medicare spending includes total nondrug Part A and B reimbursements as well as the amount contributed by beneficiaries. Sensitivity 
Analysis J reports differences in log dollars (based on natural logarithm). The difference of $5,528 in Sensitivity Analysis I does not equal 
the unadjusted difference in Medicare spending of $5,545 as expected in the standard Blinder-Oaxaca decomposition because the 
regressions rely on a complete case analysis and a limited number of observations are dropped due to missing data. The selection model 
used in Sensitivity Analysis K models beneficiary selection into a Medicare Advantage plan in 2005 or 2006 as a function of the remaining 
beneficiary characteristics used in the decomposition regressions, in addition to state-level Medicare Advantage access rates as an 
additional variable (from the Kaiser Family Foundation) to satisfy the exclusion restriction. Positive percentages indicate that the variable 
set contributes toward increasing the difference in spending between higher- and lower-spending regions whereas negative percentages 
indicate that the variable set decreases the difference. Percentages may not add up exactly to 100 due to rounding. 
b Differences are based on average predicted outcomes from generalized linear models used in the decomposition with the exception of 
Sensitivity Analyses I, J, and K which were based on the standard Blinder-Oaxaca decomposition. Regional spending level is based on 
data reported in The Dartmouth Atlas of Health Care and refers to total nondrug Part A and B spending in 2004, measured at the hospital 
referral region (HRR) level. Beneficiaries were divided into two mutually exclusive categories of higher- versus lower-regional spending on 
the basis of the spending in their HRR in 2004: HRRs below the median designate lower-spending regions (median, $6,680; range, $5,112 
to $7,324) and HRRs above the median designate higher-spending regions (median, $7,986; range, $7,330 to $11,609). 
c Sociodemographic characteristics include age, sex, race/ethnicity, educational achievement, household wealth, poverty status, marital 
status, household size, and urban status. 
d Behavioral risk factors include smoking status, alcohol consumption, body mass index, and physical activity.  
e Health status includes self-rated health, proxy respondent status (as an indirect measure of health), and death between 2004-2006. 
f Functional status includes limitations in activities of daily living and instrumental activities of daily living. 
g Insurance includes indicators for Medicare Advantage use in 2005 or 2006, discontinuous full Part A and B enrollment between 2004 and 
2006, and supplementary private insurance.  
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Table S3.6. Comparison of Medicare Advantage Beneficiaries in Higher- versus Lower-Spending Regions 
  Regional Spending Levela   
Variable Total Lower Higher Difference P Value 
 
(N = 687) (N = 351) (N = 336) 
  Age, mean (SD) 73.6 (7.1) 74.0 (7.2) 73.3 (6.9) -0.7 0.230 
Female (%) 55.2 53.6 56.8 3.3 0.388 
Race/ethnicity (%) 
        White 64.3 71.2 57.1 -14.1 0.000 
   Black 22.9 19.1 26.8 7.7 0.016 
   Hispanic 12.1 9.4 14.9 5.5 0.028 
   Other 0.7 0.3 1.2 0.9 0.163 
Educational achievement (%) 
        Less than high school 39.6 34.5 44.9 10.5 0.005 
   Complete high school 34.6 37.0 32.1 -4.9 0.178 
   More than high school 25.8 28.5 22.9 -5.6 0.095 
Household wealth (%)b 
        Quintile 1 27.1 25.1 29.2 4.1 0.228 
   Quintile 2 24.2 23.1 25.3 2.2 0.497 
   Quintile 3 19.8 18.8 20.8 2.0 0.505 
   Quintile 4 15.7 18.5 12.8 -5.7 0.040 
   Quintile 5 13.2 14.5 11.9 -2.6 0.311 
Below poverty threshold (%) 15.7 13.1 18.5 5.3 0.054 
Married (%) 59.4 62.1 56.5 -5.6 0.138 
Household size, mean (SD) 2.1 (1.2) 2.1 (1.2) 2.2 (1.3) 0.1 0.455 
Urban (%) 80.1 76.1 84.2 8.2 0.007 
Body mass index (BMI) category (%) 
        Underweight 2.4 2.3 2.4 0.1 0.934 
   Normal 31.8 33.1 30.3 -2.8 0.432 
   Overweight 39.7 39.8 39.6 -0.1 0.972 
   Obese 26.2 24.8 27.6 2.8 0.400 
Alcohol consumption (%) 
        Abstainers 62.1 59.6 64.8 5.2 0.163 
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   Light drinkers 23.7 26.1 21.2 -4.9 0.134 
   Moderate drinkers 8.9 9.7 8.1 -1.7 0.441 
   Heavy drinkersc 5.3 4.6 6.0 1.4 0.418 
Smoking status (%) 
        Nonsmoker 43.9 45.7 42.1 -3.6 0.340 
   Former smoker 42.2 42.3 42.1 -0.2 0.959 
   Current smoker 13.9 12.0 15.8 3.8 0.149 
Weekly vigorous exercise (%) 22.7 24.6 20.8 -3.7 0.244 
Weekly moderate exercise (%) 62.1 66.6 57.4 -9.1 0.014 
Weekly light exercise (%) 76.4 78.3 74.4 -3.9 0.224 
Self-rated health (%) 
        Excellent 5.8 6.8 4.8 -2.1 0.246 
   Very good 22.9 26.8 18.8 -8.0 0.012 
   Good 32.6 33.0 32.1 -0.9 0.801 
   Fair 25.5 22.2 28.9 6.6 0.046 
   Poor 13.2 11.1 15.5 4.4 0.092 
ADL limitations, mean (SD) 0.4 (1.0) 0.4 (1.0) 0.4 (1.1) 0.1 0.295 
IADL limitations, mean (SD) 0.4 (1.0) 0.4 (1.0) 0.4 (0.9) 0.0 0.681 
Cognitive functioning (%) 
        Normal 60.2 61.1 59.2 -1.9 0.609 
   Cognitive impairment without dementia 28.4 28.6 28.3 -0.3 0.931 
   Dementia 11.4 10.3 12.5 2.2 0.362 
Discontinuous full Part A and B enrollment, 
2004-06 (%) 9.3 10.3 8.3 -1.9 0.387 
Supplementary private insurance (%) 52.8 56.2 49.3 -6.9 0.070 
Abbreviations: ADL, activity of daily living; IADL, instrumental activity of daily living. 
a Regional spending level is based on data reported in The Dartmouth Atlas of Health Care and refers to total nondrug Part A and 
B spending in 2004, measured at the hospital referral region (HRR) level. Beneficiaries were divided into two mutually exclusive 
categories of higher- versus lower-regional spending on the basis of the spending in their HRR in 2004: HRRs below the median 
designate lower-spending regions (median, $6,680; range, $5,112 to $7,324) and HRRs above the median designate higher-
spending regions (median, $7,986; range, $7,330 to $11,609). Percentages may not add up exactly to 100 due to rounding. 
b Respondents’ total household wealth (excluding individual retirement accounts) was measured in quintiles based on the full 
wealth distribution of respondents in the corresponding HRS survey wave. 
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ASSOCIATION BETWEEN MEDICARE SPENDING AND BENEFICIARIES’ HEALTH,  
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Importance: There is mixed evidence that higher Medicare spending benefits patients. Little is 
known about whether the intensity of healthcare spending during and after hospitalization 
impacts patients’ health or functioning. 
Objective: To determine whether differences in healthcare spending are associated with 
beneficiaries’ health, functioning, and mortality after hospitalization.  
Design: Survey data from the nationally representative Health and Retirement Study were 
linked to Medicare claims and hospital referral region spending characteristics from the 
Dartmouth Atlas of Health Care. Instrumental variables regression was used to adjust for 
observed and unobserved differences in beneficiaries’ characteristics and to assess the effects 
of Medicare spending during the year following hospitalization on beneficiaries’ health, 
functioning, and mortality.  
Setting: Care provided in US hospital referral regions. 
Participants: Acutely ill fee-for-service Medicare beneficiaries hospitalized between 2003 and 
2010 for acute myocardial infarction, hip fracture, gastrointestinal bleeding, stroke, cancer, 
congestive heart failure, pneumonia, acute respiratory failure, and unstable angina. 
Exposures: Price-adjusted Medicare Part A and B spending during the year following 
hospitalization. 
Main Outcomes and Measures: Self-rated health status, limitations in activities of daily living 
(ADLs) and instrumental ADLs (IADLs), pain, cognitive functioning, depressive symptoms, and 
1-year mortality. Outcomes were assessed through 2013. 
Results: 2,772 Medicare beneficiaries experienced 4,685 hospitalizations. After adjusting for 
confounding due to health status, a 10% increase in price-adjusted, 1-year Medicare spending 
was associated with reductions in the probability of new IADL limitations (-1.96 percentage 




percentage points; 95% CI, -4.04 to -0.59; P=0.009), and mortality (-2.02 percentage points; 
95% CI, -3.57 to -0.46; P=0.01). There was no association between higher Medicare spending 
and self-rated health status, ADL limitations, pain, or cognitive functioning. 
Conclusions: Higher Medicare spending in the year following hospitalization was associated 
with fewer new functional limitations, depressive symptoms, and lower mortality rates, but was 
not related to other measures of health. While prior research has focused on mortality, we find 
important relationships between Medicare spending intensity and previously unstudied domains 







Marked variation in Medicare spending across regions of the United States has prompted 
intense policy debate as to whether the intensity of Medicare spending is related to beneficiaries’ 
health outcomes.123 Early studies found that Medicare patients in higher-spending regions and 
hospitals did not have lower mortality rates and experienced few differences in other measures 
of health system performance.4,5,159 More recent studies have utilized natural experiments to 
address the concern that unmeasured differences in patients’ health may bias estimates of the 
relationship between spending and outcomes. These studies found that higher acute care 
inpatient spending was associated with improved survival.127,152,258 However, this growing 
literature lacks a comprehensive assessment of outcomes other than mortality that are 
important to patients, providers, and policymakers, such as measures of health and functioning.  
 
Motivated by a comprehensive report from the Institute of Medicine highlighting post-acute care 
as a major driver of variation in spending3 and the paucity of evidence relating spending to 
functional status, we examined the relationship between Medicare spending in the year 
following hospitalization for acute illness and beneficiaries’ self-rated health status, functional 
limitations, pain, cognitive status, and depressive symptoms.  
 
METHODS 
Study Data, Population, and Period 
We used data from the Health and Retirement Study (HRS), a large, nationally representative, 
prospectively collected cohort study of older Americans that has been used to study geographic 
variation in Medicare spending.199,222,223,259,260 We linked survey measures of socioeconomic 
status, and health and functioning before and after hospitalization, to Medicare claims. During 
our study period, 91% of eligible HRS respondents consented to release their Medicare claims 





Because our research design required exact Medicare spending, we restricted our study 
population to respondents who were 65 years or older (N=8,208) and continuously enrolled in 
fee-for-service Medicare during the 365-day period starting with the index admission (N=7,121). 
To minimize confounding due to unobserved differences in patient health status, we studied a 
cohort of acutely ill respondents who were hospitalized between 2003 and 2010 for acute 
myocardial infarction, hip fracture, gastrointestinal bleeding, stroke, cancer, congestive heart 
failure, pneumonia, acute respiratory failure, and unstable angina. These diseases comprise a 
substantial percentage of admissions in the Medicare population and most have been studied 
previously in the treatment intensity literature.8,127,140,167 This cohort-based approach is similar to 
that used in prior studies, including the seminal work of Fisher and colleagues and more recent 
studies focused on acute myocardial infarction.4,5,8,127,152,159,167,258  
 
Healthcare Spending  
For each hospitalization, we calculated total Medicare Part A and B spending for the 365-day 
period beginning with inpatient admission, summing reimbursement for inpatient hospital 
(including acute care, inpatient rehabilitation, and long-term care), skilled nursing facility, home 
health or hospice, physician offices, outpatient facility, and durable medical equipment. The 
measure was price-adjusted using the ratio of price-standardized to price-unstandardized 
Medicare Part A and B spending within a respondent’s hospital referral region (HRR). HRRs 
represent regional markets for tertiary medical care and define where residents of that region 
receive the majority of their care.220 Price-adjustment removes the effects of regional variations 
in input costs, such as capital, labor, and overhead (rent and liability costs) and more accurately 





Study Outcomes  
For each hospitalization, measures of a respondent’s pre-hospitalization and post-
hospitalization health and functional status were compared using data obtained from their most 
recent HRS interviews. As such, respondents’ outcomes were evaluated at different time 
periods corresponding to their hospitalizations. On average, interviews were conducted 1.6 
years before and 1 year after hospitalization. The latest year of available HRS follow-up data 
was 2013.   
 
Respondents rated their general health status as poor, fair, good, very good, or excellent. 
Functional status was measured as a count of limitations based on respondents reports of some 
difficulty performing basic activities of daily living (ADLs; bathing, eating, dressing, walking 
across a room, and getting in or out of bed) and instrumental activities of daily living (IADLs; 
using a telephone, taking medication, handling money, shopping, and preparing meals). 
Respondents’ ratings of pain were classified as none, mild, moderate, or severe. We 
categorized cognitive functioning as either normal, cognitively impaired without dementia, or 
with dementia, using a previously validated approach.261 Depression was measured using an 8-
item symptom count adapted for the HRS from the 20-item Center for Epidemiologic Studies 
Depression (CES-D) scale, which measures depressive symptoms in the general population.262 
Outcome data obtained from proxies representing respondents were included in the main 
analysis, if available. Additional details about the outcome measures are provided in 
supplementary Table S4.1 in the Appendix. 
 
We constructed a composite outcome variable that combined information about respondents’ 
pre- versus post-hospitalization scores and their vital status into a single summary measure for 
each outcome. Respondents scored 0 if their outcome measure was the same or better when 




had died. This approach sought to mitigate potential bias from truncation-by-death 
confounding,215 in which respondents in worse states of health or functioning are less likely to 
survive to the follow-up HRS interview. For consistency with past research, we also assessed 
whether each respondent survived to 365 days following hospitalization.  
 
Statistical Analysis 
Our study design accounts for two sources of differences in spending across patients: 
differences due to underlying health, and differences due to treatments received. Because 
patients with greater severity of illness require more care and incur greater expenditures, failure 
to account for severity of illness biases estimates toward implying that greater spending is 
associated with worse health outcomes. We addressed this concern by focusing on an acutely 
ill patient population and by using instrumental variables analysis—a commonly used 
econometric technique that can resolve confounding in the key explanatory variable by using a 
predictor (the “instrument”) that is uncorrelated with unobserved health status, has no direct 
effect on health outcomes (except through its effect on respondent-level spending), and is 
strongly correlated with the endogenous explanatory variable.186  
 
Similar to prior research,127,179,181 we used HRR-level total price-adjusted Medicare spending per 
decedent in the last 2 years of life as an instrumental variable; this measure was extracted from 
The Dartmouth Atlas of Health Care.19 This choice of instrument is supported by a large body of 
literature demonstrating that significant regional variations in spending and utilization (including 
at the end of life) persist even after accounting for a comprehensive set of patient characteristics 
and health status measures.37,199 Regional end-of-life spending is highly correlated with total 
spending but less sensitive to differences in illness severity because patients at the end of life 
are plausibly similar in their health statuses.5,8,190,263 Physician beliefs and practice patterns 





We first estimated linear probability models for each outcome that did not account for 
unobserved health status. We then used two-stage least squares to estimate the same models, 
instrumenting for respondent-level spending with the end-of-life spending from the respondent’s 
HRR of residence. Regressions controlled for demographic and socioeconomic characteristics 
(age, sex, self-reported race and ethnicity, education, household wealth, and marital status), 
health behaviors (past and present smoking status, alcohol consumption, and body mass index), 
a pre-hospitalization measure of the outcome (because changes in health status may differ for 
respondents with different levels of past health), year of hospitalization, time between outcome 
assessment (for example, HRS interviews) and admission or discharge, and for the individual 
diseases comprising the study population. We did not control for comorbidities coded in 
Medicare claims in order to avoid introducing a bias associated with regional differences in 
diagnostic intensity.42 In all analyses, hospitalization was the unit of analysis, and standard 
errors were clustered by HRR. Additional details of the instrumental variable approach are 
provided in the supplemental Appendix.   
 
We conducted numerous sensitivity analyses including restricting observations to a 
respondent’s first admission during our study period, excluding hospitalization for congestive 
heart failure and pneumonia (where there is greater clinical uncertainty around the decision to 
admit), using alternative specifications of spending and outcome measures, excluding 
observations where outcome data were obtain by proxy interviews, and clustering standard 






We used Stata 13.1 (StataCorp, College Station, Texas) for all analyses. Reported P values are 
two-sided; a P value of 0.05 or less designated statistical significance. This study was approved 
by the IRB of The Johns Hopkins Bloomberg School of Public Health.  
 
RESULTS 
Survey Respondents and Hospitalizations  
A total of 8,717 HRS respondents with linked Medicare claims experienced 28,775 
hospitalizations between 2003 and 2010. We excluded 2,256 hospitalizations for respondents 
under age 65, 4,809 hospitalizations for respondents who were not Medicare fee-for-service 
beneficiaries, and 17,025 hospitalizations that did not meet diagnostic inclusion criteria. The 
remaining sample included 4,685 hospitalizations for 2,772 respondents residing in 237 HRRs 
during the study period.  
 
Table 4.1 presents respondent characteristics for all hospitalizations. The mean age was 80.7 
years; 56% were women, 23% were nonwhite, and 32% reported fair health status prior to 
hospitalization. There were few differences in respondent characteristics across HRRs with the 
following categories of end-of-life spending: low (median, $47,662; range, $34,741 to $52,262), 
intermediate (median, $59,075; range, $52,339 to $67,422), or high (median, $74,307; range, 
$67,435 to $110,969). However, notable differences were found in racial and ethnic composition, 
with a lower percentage of white (63% vs. 85%) and a higher percentage of Hispanic (17% vs. 
2%) respondents living in HRRs with high-versus-low end-of-life spending. There was no 
consistent relationship between pre-hospitalization health and HRR-level spending.  
 
Healthcare Spending 
Figure 4.1 compares respondent-level spending in HRRs with low, intermediate, and high end-




was $23,858 (interquartile range, $11,664 to $45,476) and was 31% higher when comparing 
HRRs with high-versus-low end-of-life spending ($29,879 vs. $21,794). HRR-level end-of-life 
spending—the instrumental variable—was strongly correlated with respondent-level spending 
(first stage F statistic, 38; P<0.001; Appendix Table S4.2). A $1,000 increase in HRR-level end-
of-life spending was associated with a 1.10% (95% confidence interval [CI], 0.75 to 1.50; 
P<0.001) increase in respondent-level spending (Appendix Table S4.2). 
 
Comparison of Ordinary Least Squares and Instrumental Variables Analyses  
Figure 4.2 compares the results when models were estimated by ordinary least squares or 
instrumental variables. In ordinary least squares regressions that did not account for 
confounding by severity of illness, we found that higher spending was associated with worse 
health and functional status. There was no relationship between spending and mortality. In 
contrast, the instrumental variables analyses, which adjusted for confounding by patient health 
status, showed beneficial effects of higher spending for certain outcomes, which we discuss in 
detail hereafter. 
 
Health and Functional Status 
In the instrumental variable regressions, a 10% increase in price-adjusted Medicare spending in 
the year following hospitalization was associated with a reduction in the probability that 
respondents developed new IADL limitations (-1.96 percentage points; 95% CI, -3.88 to -0.03; 
P=0.05) and new depressive symptoms (-2.31 percentage points; 95% CI, -4.04 to -0.59; 
P=0.009) compared with before hospitalization (Table 4.2). These are relative reductions of 
3.1% and 3.4% from the mean rates of new IADL limitations and depressive symptoms (63.0% 
and 68.2%), respectively. There was no significant association between higher Medicare 






Respondents died within 365 days following 37% of hospitalizations. In the instrumental variable 
regressions, a 10% increase in Medicare spending in the year following hospitalization was 
associated with a 2.02 percentage point (95% CI, -3.57 to -0.46; P=0.01) reduction in the 
probability of mortality (Table 4.2), representing a relative decrease of 5.5%.  
 
Sensitivity Analyses 
Our findings were robust across numerous sensitivity analyses. Analyses that examined only 
respondents’ first admissions or excluded hospitalizations for congestive heart failure and 
pneumonia, tested alternative outcome measure specifications, clustered standard errors on 
respondents rather than HRRs or on both respondents and HRRs, excluded respondents for 
whom outcome data were obtain by proxy interviews, included Elixhauser comorbidities, or used 
price-unadjusted measures of spending were not appreciably different from our main findings 
(Appendix Tables S4.3-S4.5). When comparing hospitalizations in HRRs in the top half of 
regional end-of-life spending to those in the bottom half, we found that, in higher-intensity 
regions, a 10% increase in respondent-level spending was associated with reductions in the 
probability of the following: new IADL limitations and depressive symptoms, worse cognitive 
status, and 1-year mortality (Appendix Table S4.6). There was no significant association 
between higher Medicare spending and outcomes in lower-intensity regions. The full results of 
all sensitivity analyses are provided in the Appendix. 
 
DISCUSSION 
Using 10 years’ of data from a large, nationally representative study and linked Medicare claims, 
we examined the effect of healthcare spending on a diverse and understudied set of outcomes 
that captured beneficiaries’ physical, cognitive, and mental health, as well as functional status, 




reductions in the likelihoods of new IADL limitations, new depressive symptoms, and 1-year 
mortality, but was not associated with other physical and mental health outcomes in the main 
analysis. Additional analyses demonstrated that in higher-intensity regions, higher spending was 
also associated with a lower likelihood of cognitive impairment. 
 
This study extends recent research that relied on administrative data, such as discharge and 
claims data, and found that higher acute care inpatient spending was associated with improved 
short-term survival.127,167,258 We instead examined total nondrug healthcare spending in the year 
following the date of admission. We used this approach because acute care inpatient and post-
acute care utilization (skilled nursing, inpatient rehabilitation, long-term care, and home health 
care) together account for most of the geographic variation in Medicare spending,35 and 
because of our interest in longer-term health and functional outcomes that may be particularly 
responsive to rehabilitative utilization during the post-acute period. Functional disability, 
cognitive impairment, and depression are highly prevalent among older Americans following 
hospitalization for serious illnesses,264-267 though little previous work has assessed whether 
variations in healthcare spending affect these domains of health. This study underscores the 
opportunities afforded by large, national surveys such as the HRS to provide estimates of 
healthcare system productivity and to identify systematic differences in measures of health and 
functioning that may not be correlated with mortality. 
 
Our instrumental variables results provide evidence of small positive returns to total (acute 
inpatient and post-acute) spending. While small in magnitude, these reductions in functional 
disability, cognitive impairment, and depressive symptoms due to greater Medicare spending 
following hospitalization could offset some of the substantial economic costs associated with 
informal care—unpaid care provided by family and friends—that many older Americans 




board reductions in Medicare spending could unintentionally limit utilization of effective care in 
addition to care that is wasteful.  
 
This study has several limitations. First, because we studied elderly Medicare fee-for-service 
beneficiaries, our results may not generalize to Medicare Advantage or commercially insured 
beneficiaries. Nevertheless, fee-for-service beneficiaries account for over 70% of all Medicare 
beneficiaries and are the predominant population studied when examining the consequences of 
variations in healthcare spending.271 Since our study focused on acutely ill beneficiaries with an 
inpatient admission, it is unknown whether similar benefits would be achieved by increasing 
spending within a healthier population. Similarly, because regions have different production 
functions, it is unclear whether increasing spending within lower-intensity regions would achieve 
results similar to those observed in higher-intensity regions.197 
 
Second, regions with higher intensities of end-of-life spending may have lower thresholds for 
hospitalizing patients for diseases such as congestive heart failure or pneumonia, whose 
admission rates—unlike heart attack or hip fracture—are subject to greater provider discretion. 
This could bias estimates toward showing that lower spending is beneficial, contrary to our main 
findings. Consistent with other studies,127,167 our sensitivity analyses suggested that the results 
were not driven by inclusion of hospitalizations for congestive heart failure or pneumonia; 
moreover, to adjust for pre-existing differences in health, we included additional covariates 
(smoking status, alcohol consumption, and body mass index), and pre-hospitalization measures 
of the outcomes, that are unrelated to the likelihood of hospital admission or regional diagnostic 
practices. Finally, our study does not disaggregate spending or suggest which sources of 
spending are beneficial. Certain post-acute spending, such as utilization of skilled nursing 




to investigate whether the intensity of utilization of different types of post-acute care services 
can improve patients’ health and functioning. 
 
CONCLUSIONS 
We leveraged a large, nationally representative and longitudinal survey of older Americans to 
examine the relationship between Medicare spending and outcomes that are rarely available in 
administrative datasets. Higher Medicare spending following hospitalization was associated with 
fewer new functional limitations and depressive symptoms, in addition to lower mortality rates, 
but was not related to other measures of health. These findings underscore the importance of 
assessing a multidimensional set of outcomes as policymakers consider interventions to reduce 





Figure 4.1. Medicare Spending Following Acute Hospitalization 
 
Respondent Medicare spending is the median of total nondrug Medicare Part A and B spending 
in the year following admission, standardized to adjust for regional differences in price. This 
includes spending on inpatient hospital care (including acute care, inpatient rehabilitation, and 
long-term care), skilled nursing facility stays, home health and hospice care, physician services, 
outpatient care, and durable medical equipment. Regional end-of-life Medicare spending is 
based on data reported in The Dartmouth Atlas of Health Care and refers to total per capita Part 
A and B spending in the last 2 years of life measured at the hospital referral region (HRR) level 
and standardized to adjust for regional differences in price. “Low” refers to HRRs equal to or 
below the 25th percentile of regional end-of-life spending (median, $47,662; range, $34,741 to 
$52,262), “intermediate” refers to HRRs above the 25th and below the 75th percentiles (median, 
$59,075; range, $52,339 to $67,422), and “high” refers to HRRs above or equal to the 75th 









Figure 4.2. Percentage Point Change in Probability of Outcomes for 10% Increase in 
Respondents’ Medicare Spending Following Hospitalization 
 
Coefficient estimates are from regressions using ordinary least squares (OLS) and two-stage 
least squares instrumental variable (IV) estimation of the outcomes on respondents’ price-
adjusted spending and covariates for demographic, health, and time characteristics. All 
outcomes other than death are measured with respect to health prior to hospitalization; for 





Table 4.1. Characteristics of Respondents' Hospitalizations by Regional Intensity of End-of-Life Spendinga  
  
Regional End-of-Life Spending  
 
All Hospitalizations Low Intermediate High  
Characteristic (N = 4,685) (N = 1,176) (N = 2,335) (N = 1,174) P Value 
Age (yr), mean (SD) 80.7 (8.6) 80.6 (8.2) 80.6 (8.7) 81.1 (8.7) 0.71 
Female sex (%) 55.5 53.4 56.1 56.2 0.43 
Race or ethnic group (%) 
    
 
   White 77.3 85.0 80.5 63.4 0.002 
   African American 14.7 12.0 14.8 17.4 0.39 
   Hispanic 6.3 1.9 3.3 16.7 0.02 
   Other 1.6 1.1 1.5 2.6 0.32 
Education level (%) 
    
 
   Some high school or less 39.3 38.6 38.5 41.7 0.72 
   High school diploma 32.8 32.4 33.3 32.3 0.91 
   More than high school 27.9 29.0 28.3 26.1 0.68 
Wealth (%)b 
    
 
   Quintiles 1-3 68.0 66.9 66.8 71.6 0.30 
   Quintiles 4 and 5 32.0 33.1 33.2 28.4 0.30 
Married (%)c 53.6 49.5 53.7 57.4 0.05 
Self-rated health status, mean (SD)d 3.6 (1.1) 3.5 (1.1) 3.6 (1.1) 3.6 (1.1) 0.41 
ADL limitations, mean (SD)e 1.0 (1.5) 0.9 (1.4) 0.9 (1.5) 1.1 (1.6) 0.006 
IADL limitations, mean (SD)f 1.0 (1.5) 0.9 (1.4) 1.0 (1.5) 1.1 (1.6) 0.29 
Pain (%) 
    
 
   None 59.9 61.3 58.5 61.3 0.28 
   Mild 8.6 8.7 8.5 8.8 0.98 
   Moderate 21.5 19.9 23.0 20.2 0.12 
   Severe 10.0 10.1 10.0 9.7 0.97 
Cognitive status (%) 
    
 
   Normal 52.1 51.7 54.4 47.8 0.03 
   Cognitive impairment without dementia 28.8 29.2 27.5 31.1 0.19 
   Dementia 19.1 19.1 18.0 21.1 0.39 
Depressive symptoms, mean (SD)g 1.8 (2.1) 1.7 (2.1) 1.8 (2.1) 1.8 (2.1) 0.14 




a Age was assessed at the time of hospitalization from respondents’ Medicare claims. All other sociodemographic and health characteristics 
were assessed from respondents’ Health and Retirement Study (HRS) surveys prior to hospitalization. Regional end-of-life Medicare spending 
is based on data reported in The Dartmouth Atlas of Health Care and refers to total Part A and B spending in the last 2 years of life, measured 
at the hospital referral region (HRR) level. “Low” refers to HRRs equal to or below the 25th percentile of regional end-of-life spending (median, 
$47,662; range, $34,741 to $52,262), “intermediate” refers to HRRs above the 25th and below the 75th percentiles (median, $59,075; range, 
$52,339 to $67,422), and “high” refers to HRRs above or equal to the 75th percentile (median, $74,307; range, $67,435 to $110,969). P values 
are from tests of the equality of means across all 3 levels of regional end-of-life spending and account for clustering of hospitalizations within 
HRRs.  
b Respondents’ total household wealth (excluding individual retirement accounts) was measured in quintiles based on the full wealth distribution 
of respondents in the corresponding HRS survey wave. 
c The precise P value was 0.052. 
d Scores for self-rated health status range from 1 (excellent) to 5 (poor). 
e Limitations in ADLs are the sum (0 – 5) of difficulties with bathing, eating, dressing, walking across a room, and getting in or out of bed. 
f Limitations in IADLs are the sum (0 – 5) of difficulties with using a telephone, taking medication, handling money, shopping, and preparing 
meals. 
g Depressive symptoms range from 0 to 8 and were assessed using an HRS adaptation of the Center for Epidemiologic Studies Depression 
scale (CES-D). 




Table 4.2. Mean Values and Changes in Measures of Health, Functional Status, and Mortality Following Hospitalizationa 
  Ordinary Least Squares Instrumental Variables 
Variable  
Mean Value 
at Follow Up 
(%) 
Change with 10% 
Increase in Spending 
(95% CI)b P Value 
Change with 10% 
Increase in Spending 
(95% CI)b P Value 
Measures of health and functional statusc      
  Worse health status  64.9 0.40 (0.21 to 0.58) <0.001 -1.17 (-2.87 to 0.54) 0.18 
  New ADL limitations  64.7 0.65 (0.50 to 0.82) <0.001 -0.51 (-2.43 to 1.41) 0.60 
  New IADL limitations 63.0 0.53 (0.33 to 0.73) <0.001 -1.96 (-3.88 to -0.03) 0.05 
  Worse pain  55.4 0.24 (0.06 to 0.42) 0.009 -0.55 (-2.29 to 1.19) 0.54 
  Worse cognitive status   58.7 0.40 (0.19 to 0.60) <0.001 -1.58 (-3.50 to 0.34) 0.11 
  New depressive symptoms  68.2 0.30 (0.10 to 0.50) 0.004 -2.31 (-4.04 to -0.59) 0.009 
Death within 365 days 36.7 -0.04 (-0.24 to 0.17) 0.71 -2.02 (-3.57 to -0.46) 0.01 
Abbreviations: ADL, activities of daily living; IADL, instrumental activities of daily living. 
a The effect of a 10% increase in price-adjusted Medicare spending in the year following hospitalization was estimated from regressions 
using ordinary least squares or two-stage least squares instrumental variables estimation, with year-specific end-of-life Medicare spending in 
the respondent’s hospital referral region (HRR) as the instrumental variable. Regressions include covariates for age, sex, race and ethnicity, 
education, household wealth, and marital status; past and present smoking status, alcohol consumption, and body mass index; year of 
hospitalization; a pre-hospitalization measure of the outcome (using each measure’s original scale); the time (in days) between outcome 
assessment (for example, HRS interviews) and admission or discharge; and for the individual diseases comprising the study population. 
Standard errors were clustered within HRRs to account for the likelihood that respondents in the same region are treated similarly. 
b Expressed as the percentage point change in the probability of the outcome (e.g., worse self-rated health status). 







We are interested in the relationship between Medicare spending and patient health.  However, 
estimates that fail to correct for unobserved patient severity are likely biased upwards because 
of a presumed positive correlation between unobserved severity of illness and spending (i.e. 
higher spending is associated with worse health outcomes). To address this concern, we 
estimated linear probability models of our composite outcome variables using two-stage least 
squares (2SLS) instrumental variables regression. In Equation 1, we predict the natural log of 
Medicare spending using total price-adjusted end-of-life (EOL) Medicare spending measured at 
the hospital-referral regional (HRR)-level as an instrument.  Equation 2 uses the predicted value 
from the first stage in a regression of patient outcomes on logged one-year Medicare spending.  
(Yi-1 refers to a pre-hospitalization measure of the outcome obtained from the most recent prior 
Health and Retirement Study interview.) 
   (1) 
   (2) 
 
2SLS estimates a local average treatment effect—the effect of healthcare spending for those 
respondents whose healthcare spending was higher as a result of residing in a region with 
higher EOL Medicare spending.273 Hospitalizations were the unit of analysis and standard errors 
were clustered at the HRR level to account for intraregional correlation.  
 
Defining the Instrumental Variable 
We selected the instrumental variable based on theory and past research. In the context of our 
study, a valid instrumental variable would be exogenous, uncorrelated with unobserved severity 
of illness, and have no direct effect on outcomes other than through its effect on respondents’ 
spending (the exclusion restriction).186 Using elements of geography as instrumental variables is 
common in the empirical health economics and health services literature.25 For example, Hadley 
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and colleagues (2011),179 Skinner and colleagues (2005),181 and Kaestner and colleagues 
(2010)127 used measures of regional or hospital-level EOL spending and utilization intensity as 
instrumental variables.  
 
Regional EOL intensity measures have been used as instruments with the premise that 
utilization measured in the last 6 months or 2 years of life is unconfounded by severity of illness 
because all patients have similar health statuses close to the EOL. Kelley and colleagues 
(2011)199 found that marked variation in EOL spending remained even after accounting for 
numerous risk-adjusters derived from HRS survey responses and Medicare claims, suggesting 
that differences in underlying health did not explain most of this variation. These EOL “look back” 
spending measures are highly correlated with “look forward” measures that sum the costs of 
care over a defined period of time for a clinically homogenous cohort.4,190 As such, EOL 
spending measures capture a region’s proclivity for utilizing health care of varying intensities. 
 
For these reasons, we used total price-adjusted Medicare spending per decedent in the last 2 
years of life as an instrumental variable, which we obtained from The Dartmouth Atlas of Health 
Care.19 The instrument was measured at the HRR level. Details about EOL utilization measures 
can be found in a Dartmouth Atlas report on chronically ill Medicare beneficiaries at the EOL.274 
In brief, the Dartmouth Atlas constructs this variable by identifying fee-for-service Medicare 
beneficiaries (with continuous enrollment in Part A and Part B) who were hospitalized with one 
of nine medical conditions in an acute care hospital in the last 2 years of life. These measures 
are then adjusted for age, sex, race, primary chronic condition, and the presence of more than 
one chronic condition. Spending is summed from the following files: Medicare Provider Analysis 
and Review (MEDPAR), Home Health Agency, Hospice, Durable Medical Equipment, Part B file, 
and Outpatient.274  
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We used linear interpolation to fill in data for the missing years (2008 and 2009). To implement 
this measure, we first assigned respondents to 1 of 306 HRRs based on their ZIP code of 
residence.19 Next, each hospitalization was assigned a value of the instrumental variable based 
on the HRR and year of hospitalization. Year-specific information was important because ZIP 
codes are added and removed over time and the HRRs associated with them also change over 
time.  
 
Sensitivity Analyses  
Appendix Tables S4.3 through S4.6 present the results of the following sensitivity analyses: 
A. Only respondents’ first (index) admission during the study period included 
B. Removal of congestive heart failure (CHF) and pneumonia hospitalizations from the 
study population 
C. Standard errors clustered by respondents rather than HRRs 
D. Standard errors clustered by respondents and HRRs 
E. Alternative composite outcome measure that only codes deaths following respondents’ 
terminal hospitalizations 
F. Outcomes coded on original scales—survivors only 
G. Outcomes coded on original scales—survivors and decedents 
H. Exclusion of pre-hospitalization measure of the outcome from the model 
I. Exclusion of proxy interviews after hospitalization from the study population  
J. Price-unadjusted measures of respondent- and HRR-level spending  
K. Inclusion of Elixhauser comorbidities 
L. Comparison of hospitalizations in high versus low EOL spending HRRs
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Table S4.1. Outcome Measure Definitions for Original Scalesa 
Measure Definition 
Self-rated health status Rated (1 – 5) excellent, very good, good, fair, poor 
ADL limitations 
Sum (0 – 5) of some difficulties bathing, eating, 
dressing, walking across a room, and getting in or out 
of bed 
IADL limitations 
Sum (0 – 5) of some difficulties with using a telephone, 
taking medication, handling money, shopping, 
preparing meals 
Cognitive function Assessed (1 – 3) as normal, CIND, dementia 
Pain Rated (0 – 3) as none, mild, moderate, or severe 
Depression (CES-D)275 
Sum (0 – 8) of affirmative responses to feeling 
depressed, sad, lonely, everything was an effort, 
restless sleep, could not get going, and negative 
responses to feeling happy, and enjoying life 
Abbreviations: ADL, activities of daily living; IADL, instrumental activities of daily living; CIND, cognitive 






Table S4.2. First Stage Regression: Relationship between Respondent Medicare 
Spending and Regional End-of-Life Spendinga 
Variable Coefficient (95% CI) 
HRR-level per capita Medicare spending 
($1,000s) in last two years of life 
0.011 (0.0075 to 0.015) 
Age less than 70 0.029 (-0.098 to 0.16) 
Age 75 - 79 -0.093 (-0.19 to 0.0083) 
Age 80 - 84 -0.15 (-0.27 to -0.029) 
Age 85 - 89 -0.079 (-0.19 to 0.033) 
Age 90 and above -0.25 (-0.39 to -0.12) 
Female -0.0025 (-0.077 to 0.072) 
Black race 0.11 (0.011 to 0.20) 
Other race 0.053 (-0.21 to 0.31) 
Hispanic -0.010 (-0.16 to 0.14) 
High school diploma -0.012 (-0.097 to 0.073) 
More than high school -0.0076 (-0.11 to 0.092) 
Wealth quintile 2 0.026 (-0.064 to 0.12) 
Wealth quintile 3 -0.12 (-0.23 to -0.017) 
Wealth quintile 4 -0.090 (-0.20 to 0.020) 
Wealth quintile 5 -0.13 (-0.25 to -0.013) 
BMI: underweight -0.014 (-0.16 to 0.13) 
BMI: overweight 0.035 (-0.032 to 0.10) 
BMI: obese 0.088 (-0.0092 to 0.19) 
Drinks alcohol -0.0070 (-0.077 to 0.063) 
Nonsmoker -0.040 (-0.12 to 0.035) 
Current smoker -0.037 (-0.15 to 0.078) 
Divorced/separated -0.11 (-0.24 to 0.016) 
Widowed -0.025 (-0.11 to 0.056) 
Never married -0.042 (-0.21 to 0.12) 
Admitted 2003 0.12 (-0.40 to 0.64) 
Admitted 2005 0.062 (-0.038 to 0.16) 
Admitted 2006 0.023 (-0.075 to 0.12) 
Admitted 2007 0.025 (-0.076 to 0.13) 
Admitted 2008 -0.013 (-0.12 to 0.090) 
Admitted 2009 0.047 (-0.069 to 0.16) 
Admitted 2010 -0.25 (-0.40 to -0.092) 
Days since prior interview 0.000069 (-0.000016 to 0.00015) 
Days since discharge 0.00022 (0.00011 to 0.00034) 
Acute myocardial infarction 0.12 (0.034 to 0.21) 
Pneumonia -0.27 (-0.36 to -0.18) 
Cancer 0.021 (-0.11 to 0.16) 
Stroke -0.099 (-0.19 to -0.0026) 
Hip fracture 0.42 (0.32 to 0.51) 
Gastrointestinal bleeding -0.39 (-0.56 to -0.22) 
Acute respiratory failure 0.11 (-0.028 to 0.24) 
Unstable angina -0.39 (-0.70 to -0.090) 
Baseline self-rated health status 0.048 (0.018 to 0.078) 
Constant 9.30 (9.06 to 9.53) 
Kleibergen-Paap Wald statistic 38.0 
 
 103 
Cragg-Donald F statistic 57.5 
Abbreviations: HRR, hospital referral region; BMI, body mass index. 
a A respondent’s log-transformed Medicare spending in the year following hospitalization was 
regressed on HRR-level per capita Medicare spending in last two years of life in the 
respondent’s HRR of residence and other covariates. Both measures of spending were 
standardized to adjust for regional differences in price. The Cragg-Donald F statistic and 
Kleibergen-Paap Wald statistic are tests for weak instruments; the Kleibergen-Paap Wald test is 
a robust version of the Cragg-Donald F statistic. A commonly used rule of thumb proposed by 






Table S4.3. Sensitivity Analyses A – D, Changes in Measures of Health, Functional Status, and Mortality Associated with a 
10% Increase in Medicare Spendinga 
Sensitivity Analysis Main A B C D 
First-Stage F Statisticb 38 24 33 26 37 
Sample Size 4,426 2,621 2,129 4,426 4,426 
Measures of health and functional 
statusc 
     
     Worse health status -1.17 (0.87) 0.37 (0.98) -0.0049 (1.10) -1.17 (0.93) -1.17 (0.87) 
     New ADL limitations  -0.51 (0.98) -0.24 (1.21) -0.59 (1.09) -0.51 (0.88) -0.51 (0.98) 
     New IADL limitations  -1.96 (0.98)* -1.79 (1.16) -1.17 (1.13) -1.96 (0.97)* -1.96 (0.98)* 
     Worse pain  -0.55 (0.89) 0.70 (0.95) -0.84 (1.14) -0.55 (0.91) -0.55 (0.90) 
     Worse cognitive status -1.58 (0.98) 0.35 (1.12) -1.37 (1.27) -1.58 (1.03) -1.58 (0.99) 
     New depressive symptoms  -2.31 (0.88)** -2.19 (1.33) -2.14 (1.20) -2.31 (1.05)* -2.31 (0.89)** 
Death within 365 days -2.02 (0.79)* -1.89 (0.96)* -1.41 (0.80) -2.02 (0.91)* -2.02 (0.81)* 
Abbreviations: ADL, activities of daily living; IADL, instrumental activities of daily living. 
a The effect of a 10% increase in price-adjusted Medicare spending in the year following hospitalization was estimated using two-stage least 
squares instrumental variables estimation, with year-specific end-of-life Medicare spending in the respondent’s hospital referral region (HRR) as 
the instrumental variable. Regressions include covariates for age, sex, race and ethnicity, education, household wealth, and marital status; past 
and present smoking status, alcohol consumption, and body mass index; year of hospitalization; a pre-hospitalization measure of the outcome; 
the time (in days) between outcome assessment (for example, HRS interviews) and admission or discharge; and for the individual diseases 
comprising the study population. Standard errors were clustered within HRRs to account for the likelihood that respondents in the same region 
are treated similarly. Estimates are expressed as the percentage point change in the probability of the outcome (e.g., worse self-rated health 
status; standard errors are in parentheses and asterisks denote statistical significance as follows: * for P < 0.05, ** for P < 0.01, *** for P < 
0.001.  
b First stage F statistic is from the Kleibergen-Paap Wald test. 





Table S4.4. Sensitivity Analyses E – G, Changes in Measures of Health, Functional Status, and Mortality Associated with a 
10% Increase in Medicare Spendinga 
Sensitivity Analysis Mainc Ec Fd Gd 
First-Stage F Statisticb 38 28 22 38 
Sample Size 4,426 3,341 2,577 4,426 
Measures of health and functional 
status 
    
     Worse health status -1.17 (0.87) -1.12 (0.86) -0.013 (0.026) -0.037 (0.023) 
     New ADL limitations  -0.51 (0.98) -0.36 (1.06) -0.0012 (0.048) -0.063 (0.050) 
     New IADL limitations  -1.96 (0.98)* -2.13 (1.09) -0.030 (0.059) -0.090 (0.054) 
     Worse pain  -0.55 (0.89) -0.27 (0.95) 0.034 (0.031) -0.022 (0.034) 
     Worse cognitive status -1.58 (0.98) -1.60 (1.00) -0.0078 (0.019) -0.031 (0.022) 
     New depressive symptoms  -2.31 (0.88)** -2.67 (0.97)** -0.13 (0.056)* -0.16 (0.063)** 
Death within 365 days -2.02 (0.79)* -2.02 (0.79)* -2.02 (0.79)* -2.02 (0.79)* 
Abbreviations: ADL, activities of daily living; IADL, instrumental activities of daily living. 
a The effect of a 10% increase in price-adjusted Medicare spending in the year following hospitalization was estimated using two-stage least 
squares instrumental variables estimation, with year-specific end-of-life Medicare spending in the respondent’s hospital referral region (HRR) as 
the instrumental variable. Regressions include covariates for age, sex, race and ethnicity, education, household wealth, and marital status; past 
and present smoking status, alcohol consumption, and body mass index; year of hospitalization; a pre-hospitalization measure of the outcome; 
the time (in days) between outcome assessment (for example, HRS interviews) and admission or discharge; and for the individual diseases 
comprising the study population. Standard errors were clustered within HRRs to account for the likelihood that respondents in the same region 
are treated similarly. Estimates are expressed as the percentage point change in the probability of the outcome (e.g., worse self-rated health 
status; standard errors are in parentheses and asterisks denote statistical significance as follows: * for P < 0.05, ** for P < 0.01, *** for P < 
0.001.  
b First stage F statistic is from the Kleibergen-Paap Wald test. 
c Outcomes coded as binary variables such that same or better health compared with before hospitalization = 0 and worse health or death = 1.  
d Outcomes coded as scales or counts in these analyses, as in Appendix Table S4.1. For example, in Analysis F, self-rated health is coded as 
1=excellent to 5=poor. Sensitivity Analysis F includes only survivors; G includes survivors and decedents with decedents coded to a new level 







Table S4.5. Sensitivity Analyses H – K, Changes in Measures of Health, Functional Status, and Mortality Associated with a 
10% Increase in Medicare Spendinga 
Sensitivity Analysis Main H I J K 
First-Stage F Statisticb 38 40 27 96 38 
Sample Size 4,426 4,428 3,897 4,426 4,426 
Measures of health and functional 
statusc 
     
     Worse health status -1.17 (0.87) -1.47 (0.91) -0.90 (0.87) -0.83 (0.55) -1.03 (0.78) 
     New ADL limitations  -0.51 (0.98) -0.46 (0.98) -0.20 (1.02) -0.70 (0.61) -0.41 (0.82) 
     New IADL limitations  -1.96 (0.98)* -1.91 (0.98) -2.70 (0.96)** -1.41 (0.63)* -1.85 (0.84)* 
     Worse pain  -0.55 (0.89) -0.59 (0.88) -0.26 (0.88) -0.13 (0.57) -0.52 (0.77) 
     Worse cognitive status -1.58 (0.98) -1.59 (0.96) -1.36 (0.96) -1.01 (0.63) -1.49 (0.85) 
     New depressive symptoms  -2.31 (0.88)** -2.26 (0.97)* -2.31 (0.88)** -1.98 (0.55)*** -2.33 (0.84)** 
Death within 365 days -2.02 (0.79)* -2.02 (0.79)* -2.51 (0.89)** -1.50 (0.61)* -1.89 (0.82)* 
Abbreviations: ADL, activities of daily living; IADL, instrumental activities of daily living. 
a The effect of a 10% increase in price-adjusted Medicare spending in the year following hospitalization was estimated using two-stage least 
squares instrumental variables estimation, with year-specific end-of-life Medicare spending in the respondent’s hospital referral region (HRR) as 
the instrumental variable. Regressions include covariates for age, sex, race and ethnicity, education, household wealth, and marital status; past 
and present smoking status, alcohol consumption, and body mass index; year of hospitalization; a pre-hospitalization measure of the outcome; 
the time (in days) between outcome assessment (for example, HRS interviews) and admission or discharge; and for the individual diseases 
comprising the study population. Standard errors were clustered within HRRs to account for the likelihood that respondents in the same region 
are treated similarly. Estimates are expressed as the percentage point change in the probability of the outcome (e.g., worse self-rated health 
status; standard errors are in parentheses and asterisks denote statistical significance as follows: * for P < 0.05, ** for P < 0.01, *** for P < 
0.001.  
b First stage F statistic is from the Kleibergen-Paap Wald test.  





Table S4.6. Comparison of Hospitalizations in High versus Low End-of-Life (EOL) Spending Hospital Referral Regions 
(Sensitivity Analysis L)a 
 
Ordinary Least Squares Instrumental Variables 
 
Low HRRs High HRRs Low HRRs High HRRs 
Sample Size 2,245 2,181 2,245 2,181 
First-Stage F Statisticb N/A N/A 1 39 
Measures of health and functional statusc 
         Worse health status 0.34 (0.12)** 0.43 (0.13)** 4.48 (7.16) -1.98 (1.01) 
     New ADL limitations 0.71 (0.11)*** 0.59 (0.13) 12.2 (10.9) -1.31 (1.24) 
     New IADL limitations 0.50 (0.13)*** 0.56 (0.16)*** 1.75 (4.56) -2.19 (1.11)* 
     Worse pain 0.26 (0.13) 0.21 (0.14) 11.8 (11.4) -1.51 (1.05) 
     Worse cognitive status 0.38 (0.13)** 0.41 (0.17)* 11.5 (13.9) -2.35 (1.09)* 
     New depressive symptoms 0.15 (0.12) 0.45 (0.16)** 12.5 (25.7) -3.96 (0.91)*** 
Death within 365 days -0.19 (0.14) 0.10 (0.15) -5.40 (5.30) -2.82 (1.07)** 
Abbreviations: ADL, activities of daily living; IADL, instrumental activities of daily living. 
a Hospitalizations were stratified at the median ($59,063) of regional price-adjusted EOL spending intensity to create high versus low groups. The 
effect of a 10% increase in price-adjusted Medicare spending in the year following hospitalization was estimated from regressions using ordinary 
least squares or two-stage least squares instrumental variables estimation, with year-specific end-of-life Medicare spending in the respondent’s 
hospital referral region (HRR) as the instrumental variable. Regressions include covariates for age, sex, race and ethnicity, education, household 
wealth, and marital status; past and present smoking status, alcohol consumption, and body mass index; year of hospitalization; a pre-
hospitalization measure of the outcome; the time (in days) between outcome assessment (for example, HRS interviews) and admission or 
discharge; and for the individual diseases comprising the study population. Standard errors were clustered within HRRs to account for the 
likelihood that respondents in the same region are treated similarly. Estimates are expressed as the percentage point change in the probability of 
the outcome (e.g., worse self-rated health status; standard errors are in parentheses and asterisks denote statistical significance as follows: * for P 
< 0.05, ** for P < 0.01, *** for P < 0.001.  
b First stage F statistic is from the Kleibergen-Paap Wald test. 











SUMMARY OF FINDINGS 
This dissertation has used nationally representative survey data from the Health and Retirement 
Study (HRS) linked to Medicare claims to examine (1) whether health behaviors and modifiable 
risk factors—smoking status, alcohol consumption, body mass index (BMI), and physical 
activity—contribute to geographic variation in Medicare spending, and (2) the effect of Medicare 
spending on a diverse and understudied set of outcomes that captured beneficiaries’ physical, 
cognitive, and mental health and functioning, as well as mortality.  
 
Dissertation results demonstrated that in the general fee-for-service Medicare population, 
behavioral risk factors collectively explained 7% of the difference in spending between higher- 
and lower-spending regions; therefore, the majority of the difference was not explained by 
beneficiary characteristics. Among hospitalized beneficiaries, higher Medicare spending 
following hospitalization was associated with minor reductions in the likelihood of new limitations 
in instrumental activities of daily living (IADLs), new depressive symptoms, and 1-year mortality. 
In the main analyses, higher Medicare spending following hospitalization was not associated 
with other physical and mental health outcomes.  
 
This dissertation provides policymakers with new information about the importance of behavioral 
risk factors as determinants of regional variation in Medicare spending and the impact that 
healthcare spending has on multiple dimensions of health and functioning among Medicare 
beneficiaries. 
 
DISCUSSION OF FINDINGS 
Chapter 2 (Manuscript 1) was a review of existing literature on the determinants and 
consequences of geographic variation in healthcare spending. This existing literature exhibited 
notable gaps that reflected a lack of studies concerning the potential explanatory role of health 
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behaviors and modifiable risk factors on geographic variation in spending, as well as a paucity 
of studies examining the consequences of regional spending differences on beneficiaries’ health 
and functional outcomes. Andersen’s model of health services utilization was adapted in this 
dissertation as a conceptual framework that integrated these determinants and outcomes.  
 
To address these gaps in the literature, survey data from the HRS were linked to Medicare 
claims data and regional spending data from The Dartmouth Atlas of Health Care. Together, 
these data sources achieved broad national geographic coverage by combining data on 
healthcare utilization (via the claims) with health and functioning outcomes and behaviors (via 
the survey).218,219  
 
Chapter 3 (Manuscript 2) assessed the extent to which beneficiaries’ smoking status, alcohol 
consumption, BMI, and physical activity (among other individual-level characteristics) 
contributed to regional differences in price-adjusted Medicare spending (the dependent variable).  
 
Chapter 4 (Manuscript 3) evaluated the impact of price-adjusted Medicare spending, as an 
independent variable, on beneficiaries’ health and functional outcomes (the dependent 
variables) following acute hospitalization between 2003 and 2010 for acute myocardial infarction, 
hip fracture, gastrointestinal bleeding, stroke, cancer, congestive heart failure, pneumonia, 
acute respiratory failure, or unstable angina. Because all measures of Medicare spending were 
price-adjusted, these measures better reflect differences in the utilization of services (rather 
than differences in price). Importantly, the study populations in Chapters 3 and 4 differed: 
Chapter 3 included all Medicare beneficiaries, age 65 or older, in fee-for-service Medicare in 
2004, whereas Chapter 4 focused on a subset of beneficiaries who similarly were age 65 or 
older and in fee-for-service Medicare, but were hospitalized for the specific aforementioned 
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diseases between 2003 and 2010. Here, discussion of the main findings from these empiric 
chapters is reiterated. Additional details can be found in each corresponding chapter. 
 
The results reported in Chapter 3 were largely consistent with prior research. Using data from 
the Medicare Current Beneficiary Survey (MCBS), Sutherland and colleagues (2009) found that 
measures of blood pressure, diabetes, BMI, smoking history, and self-rated health explained 
18% of the differences in spending between the highest- and lowest-spending regions.38 
Zuckerman and colleagues (2010) also used the MCBS but extended the analysis of Sutherland 
and colleagues by adding over 10 additional health variables collected in the MCBS—among 
these, the presence and diagnosis of specific diseases, and whether beneficiaries died or had 
proxy respondents—and found that health factors explained 29% of the regional differences in 
spending.37 Finkelstein and colleagues (2014) identified that patient characteristics may explain 
a larger share of regional variation in utilization—between 23 and 50%, depending on the 
analysis—with much of the variation attributable to health factors.276 However, this study did not 
directly assess the choices that patients make that influence health (such as health behaviors) 
and information about health is ultimately still conveyed through claims data and, by extension, 
physician coding practices. When viewed collectively, the results reported in Chapter 3 and the 
results of this prior research suggest that beneficiary characteristics account for a nontrivial 
proportion of regional variation in Medicare spending, but much of the variation remains 
unexplained by beneficiary characteristics. 
 
However, the results reported in Chapter 3 and this prior literature differ from two recent studies 
which determined that patient characteristics account for the majority of regional variation in 
healthcare spending. In the first contradictory study, Reschovsky and colleagues (2013) 
implemented a modified version of Medicare’s Hierarchical Condition Categories model—a risk 
adjustment model based on billing data—by including only diagnoses they deemed less 
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susceptible to physician discretionary behavior. They found that population health explained 
between 75% and 85% of spending variations.39 However, this study, which was based on a 
sample of physicians rather than on patients, remains susceptible to biases associated with the 
lower diagnostic thresholds in higher-intensity regions;42,44 this study may also have over-
adjusted regional differences in spending by using the Hierarchical Condition Categories 
model.40,41  In order to address the concern of using potentially endogenous measures of health 
conditions, Chapter 3 included a sensitivity analysis which added the following variables to the 
regression models used in the decomposition analysis: the self-reported presence of high blood 
pressure, diabetes, cancer, lung disease, heart disease, stroke, psychiatric condition, or arthritis, 
as well as an additional variable that summed the number of self-reported health conditions. In 
total, 16% of the difference in Medicare spending comparing higher-versus-lower-spending 
regions was explained by beneficiaries’ characteristics when this additional set of potentially 
endogenous variables was included. This result that is virtually identical to the main analysis 
which lacked these variables (in which 17% was explained by beneficiary characteristics). The 
lack of sensitivity of the results to these additional variables may be due in part to the use of 
self-reported health condition measures. Unlike health conditions coded by physicians and 
captured in Medicare claims data—which are known to be susceptible to biases related to 
regional variation in physicians’ diagnostic practices—these self-reported health condition 
measures may be less susceptible to such biases. In the second contradictory study, Louise 
Sheiner (2014) found that 81% of the state-level variation in Medicare spending could be 
explained by a limited set of aggregate demographic and health measures.245 By using the state 
rather than the individual as the unit of analysis, this study is susceptible to the ecological fallacy 
that the aggregate factors that explain variation at the state level may not be the same factors 
that explain variation at the patient level.246 Furthermore, both studies by Reschovsky and 
Sheiner contradict a diverse literature supporting the importance of provider factors as 
determinants of geographic variation in spending. Within that literature, past studies have 
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demonstrated that persistent variations in spending exist at the end of life among similarly ill 
patients,199 that physicians' preferences and beliefs are geographically correlated and outweigh 
patients' preferences in driving utilization,94 and that physicians in higher-spending regions are 
more likely to recommend discretionary services (e.g., tests of unproven benefit) and to 
schedule more frequent return visits when compared to physicians in lower-spending regions.96 
 
While Chapter 3 focused on beneficiaries’ Medicare spending as a dependent variable, Chapter 
4 instead used Medicare spending as an independent variable. Therefore, Chapter 4 was 
predominantly interested in the effects of healthcare utilization on beneficiaries’ health and 
functional outcomes following hospitalization. Among hospitalized beneficiaries, higher 
Medicare spending following hospitalization was associated with only minor reductions in the 
likelihood of new IADL limitations, new depressive symptoms, and 1-year mortality. In the main 
analyses, no associations were observed between higher spending and self-rated health status, 
limitations in activities of daily living (ADL), pain, or cognitive functioning.  
 
Chapter 4 extended recent research that used discharge and claims data, focusing mainly on 
the effect of higher acute care inpatient spending on short-term survival, and found that higher 
acute care inpatient spending was associated with improved survival.127,167,258 Because the 
Institute of Medicine’s (IOM) 2013 report, Variation in Health Care Spending: Target Decision 
Making, Not Geography, emphasized that acute care inpatient and post-acute care utilization 
(skilled nursing, inpatient rehabilitation, long-term care, and home health care) together account 
for most of the geographic variation in Medicare spending,35 Chapter 4 results instead examined 
total nondrug healthcare spending in the year following the date of inpatient admission in order 
to include rehabilitative utilization during the post-acute period that might be particularly 
impactful on longer-term health and functional outcomes. Similar to the results of other studies 
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in this literature that used instrumental variables estimation, Chapter 4 identified modest but 
beneficial effects of higher spending.  
 
POLICY IMPLICATIONS  
This dissertation has examined topics that are currently of considerable interest to 
policymakers: application of patient-reported outcomes in research,277 geographic variation in 
Medicare spending,35,123 and the impact of health behaviors on healthcare utilization.17,82 The 
specific policy implications of each empiric manuscript are discussed in Chapters 3 and 4, 
respectively. The focus of this section centers on reconciling the policy implications of the 
findings from each chapter.  
 
At first blush, the findings of Chapters 3 and 4 appear to have contradictory policy implications—
the former suggesting that improvements in beneficiaries’ health behaviors and modifiable risk 
factors could potentially reduce Medicare spending in higher-spending regions, and the latter 
suggesting that higher spending may be beneficial for certain health and functional outcomes, in 
which case, implying that reducing spending would be disadvantageous.  However, it is 
necessary to recall that these chapters presented results from different study populations and 
the results of one chapter should not be generalized to the other. Chapter 3 included general 
fee-for-service Medicare beneficiaries in 2004, whereas Chapter 4 focused on beneficiaries who 
were hospitalized for acute episodes of specific diseases. As such, the study population in 
Chapter 4 was expected, on average, to have worse health status than the general Medicare 
population. While increased spending within this hospitalized population may yield benefits, it is 
unknown whether increasing spending in a healthier population (such as the study population 
used in Chapter 3) would achieve similar benefits. Analogously, Chapter 3 suggests, for 
example, that increasing rates of physical activity in higher-spending regions may present an 
opportunity to reduce Medicare spending in these regions through improvements in 
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beneficiaries’ health. Such health improvements may reduce the likelihood of hospitalization for 
the health conditions that comprised the study population in Chapter 4, which would be a benefit 
to both the Medicare program and its beneficiaries. However, conditional on being hospitalized, 
greater intensity of utilization may nevertheless offer benefits to sicker beneficiaries. The 
implications of these results should not be conflated. 
 
Findings reported in Chapter 3 also suggest that policies focused on healthcare providers—
such as policies that would geographically adjust provider payments—could unfairly reward or 
penalize providers in certain regions if beneficiary characteristics are not adequately accounted 
for in regional comparisons. Chapter 4 further suggests that policies that attempt to reduce 
geographic variation in spending through across-the-board reductions in Medicare spending 
could unintentionally limit utilization of care that is effective in addition to care that is wasteful. 
As such, dissertation findings support existing calls for caution in attempting to implement any 
policies that reduce either aggregate spending or that target higher-spending regions.3  
 
STRENGTHS AND LIMITATIONS 
This dissertation has several noteworthy strengths. First, the dissertation has leveraged a novel 
dataset—the HRS linked to Medicare claims—to include a richer set of variables than many 
previous studies. These variables included the health behaviors and modifiable risk factors of 
smoking status, alcohol consumption, BMI, and physical activity, as well as household wealth, 
poverty status, household size, limitations in ADLs and IADLs, pain, cognitive status, and 
depressive symptoms.  
 
Second, by focusing on behavioral risk factors, as reported in Chapter 3, we sought to isolate 
the importance of a set of lifestyle characteristics that are both the antecedent contributors to or 
causes of costly health conditions as well as factors that are potentially mutable. In contrast, 
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prior studies have emphasized beneficiary characteristics regardless of whether those 
characteristics lend to interventions or modifications that could attenuate spending and improve 
health. A large body of public health research, and the results of health promotion programs and 
interventions that can potentially mitigate these behavioral risk factors, underscore the 
substantial opportunity to reduce morbidity, mortality, and healthcare costs through lifestyle 
changes.240-244 Similarly, the results reported in Chapter 4 extend existing literature on the 
consequences of geographic variation in spending beyond its traditional reliance on mortality. 
This is vital because much of healthcare utilization does not necessarily impact mortality, but 
rather affects physical, cognitive, and mental health and functioning.  Providing evidence of the 
benefits to healthcare utilization for these additional outcomes is an important strength and 
contribution of this dissertation.  
 
Third, this dissertation has used econometric methods in an effort to facilitate causal inference 
for questions salient to policymakers. Instrumental variables estimation was used to estimate 
causal effects of healthcare spending and utilization on outcomes, which is an improvement on 
the observational research in existing literature. Separately, regression decomposition 
techniques from labor economics were used to quantify the contribution of health behaviors and 
modifiable risk factors and to explain variations in spending and utilization across regions. With 
these strengths, this dissertation contributes to the ongoing debate over the determinants and 
consequences of geographic variation in Medicare spending. 
 
This dissertation, nevertheless, has several limitations. The specific limitations of the empiric 
manuscripts were discussed in their respective chapters. Here, the discussion centers on the 
most important limitations for the dissertation as a whole. First, selection bias—largely related to 
unobserved confounding by severity of illness—is one of the most important threats to validity. 
The study design of Chapter 4 specifically sought to mitigate this. As discussed in Chapter 2, 
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common approaches to risk adjustment, such as the Elixhauser or Charlson comorbidity 
schemes, rely on identifying comorbidities present in Medicare claims.33 These approaches 
assume that the frequency of diagnosis of comorbidities is independent of intensity of 
observation, an assumption that several studies have demonstrated is not strictly tenable.41-44 
Appropriate risk adjustment is an area of active research in the geographic variations field.39 It is 
especially important when studying elderly patients because medical care may not improve their 
initial health states but rather attenuate the deterioration of their health status relative to the 
absence of medical intervention.179  
 
In Chapter 4, concerns related to risk adjustment were addressed by: (1) identifying more 
homogenous disease-specific cohorts that exhibited “low variation” (and therefore were less 
subject to supply factors or observational intensity because they lend to straightforward 
diagnoses and consistently result in hospitalization); (2) considering the inclusion of additional 
covariates derived directly from respondents—(self-reported smoking status, alcohol 
consumption, and BMI)—variables that were more likely to be free from bias due to regional 
diagnostic practices compared with comorbidities present in Medicare claims;41 and (3) using 
instrumental variables estimation, which could mitigate biases from unmeasured confounders, 
including severity of illness.  
 
In addition, the decomposition technique used in Chapter 3 did not necessarily estimate causal 
effects or elucidate underlying mechanistic pathways of behavioral risk factors on spending and 
utilization, but, nonetheless, provided salient information about the drivers of utilization across 
regions. Similarly, Chapter 4 reported using aggregate measures of spending, but those did not 
clarify the causal chain between higher utilization and fewer new functional limitations and 
depressive symptoms, and lower mortality rates. Additional research is needed to better 




Finally, although fee-for-service Medicare enrollment represents approximately 70% of all 
Medicare beneficiaries,278 these dissertation findings may have limited generalizability to 
patients outside of fee-for-service Medicare, including beneficiaries enrolled in Medicare 
Advantage plans or privately insured Americans. The IOM report and recent studies have 
emphasized important differences between Medicare and private insurance markets in terms of 
the factors that explain geographic variation in healthcare spending.3,54,279 Whereas differences 
in the quantity of services utilized appears to explain variation in Medicare spending, price 
variation is responsible for roughly 70% of geographic variation in spending for privately insured 
beneficiaries (and quantity of services used is responsible for only 15%).123  
 
FUTURE RESEARCH 
This dissertation suggests several avenues for future research.  First, future studies could take 
the health and functional outcomes reported in Chapter 4 and apply them to specific clinical 
populations—such as survivors of critical illnesses who incur long recoveries following hospital 
discharge—for which the consequences of regional variation are poorly characterized because 
those data are not captured in administrative datasets. There is wide variation across hospitals 
in intensive care unit (ICU)-admitting patterns and utilization, including admissions for patients 
at low risk of death,280 and this variation is not explained by observable patient or hospital 
factors.281 This variation may be emblematic of a lack of professional agreement about how to 
optimally use the ICU or for which patients it is the appropriate site of care,282 and, as such, this 
may signal possible overuse of ICU care. More frequent use of the ICU, particularly in patient 
populations with little need for it, may increase the risk of iatrogenic complications (such as 
bloodstream infections and ventilator-associated pneumonia).281 While one recent study 
examining an apparently discretionary patient population with pneumonia found that ICU 
admission was associated with lower mortality and no significant difference in costs,283 no large-
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scale studies have estimated causal effects of regional differences in ICU utilization on physical, 
cognitive, and mental health and functioning. Better understanding of the consequences of 
variations in ICU utilization is vital to informing physicians’ admitting decisions and addressing 
policy questions about the utility of expanding the ICU bed supply for the aging population.284 
This is especially important given the staggering cost of critical care, which is growing rapidly 
and is expensive to the U.S. healthcare system,285 with aggregate costs exceeding 1% of U.S. 
gross domestic product.286  
 
Second, future studies could use econometric methods similar to those used in this dissertation 
to study the consequences of regional variation in healthcare utilization in private health 
insurance markets. Third, this dissertation has highlighted the opportunities offered by nationally 
representative surveys such as the HRS for studying the relevance of beneficiary 
characteristics—opportunities that are rarely available in administrative datasets alone. Chapter 
3, specifically, suggests the potential for improved risk adjustment if health behaviors and 
modifiable risk factors were collected from other data sources, such as electronic health records. 
Moreover, future studies can account for these factors when modelling healthcare spending as 
a function of beneficiary characteristics. 
 
Finally, the results of this dissertation point toward the need in the future to look more closely at 
provider characteristics—specifically, which services generate health benefits and which 
provider characteristics contribute to regional variation in spending (and whether those 
characteristics are acceptable forms of variation). Given the relative importance of non-
beneficiary characteristics as emphasized in Chapter 3, possible provider factors for future 
study may include physicians’ education and training, their professional interactions, and local 




Viewed collectively, these future lines of inquiry can inform efforts to improve healthcare quality 
and lower costs in the U.S. Doing so is critical to ensuring the optimal care of Medicare 
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University, Baltimore, MD 
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Program or Project Development  
 
Improving Health Outcomes—Blood Pressure: A Quality Improvement Collaborative in 












Director, Johns Hopkins Student Program in Quality, Patient Safety and Risk 
Management, Johns Hopkins School of Medicine, Baltimore, MD 
 
2005-2011 
Weinberg Perioperative Clinical Services Team, Weinberg Surgical Suite, Johns Hopkins 





University of Rochester Medical Center, Rochester, NY 2014-2015 
Clinica Las Condes, Santiago, Chile (Johns Hopkins Medicine International) 2007 
Testimony 
 




Professional Society Memberships 
 
Association of Academic Physiatrists 2015-present 
American Congress of Rehabilitation Medicine 2015-present 
International Society of Physical Medicine and Rehabilitation 2015-present 
American Academy of Physical Medicine and Rehabilitation 2014-present 
AcademyHealth 2013-present 
American Society of Anesthesiologists 2012-2013 
Phi Beta Kappa Honor Society 2009-present 
Association of Marshall Scholars 2009-present 
Truman Scholars Association 2008-present 
Golden Key International Honor Society 2007-present 





Journal Peer Review 
 
British Medical Journal (BMJ) Group: BMJ Quality & Safety, Applied Health Economics 










National Quality Scholar, American College of Medical Quality (ACMQ)  2012 
Graduate Scholarship Award, Golden Key International Society 2012 
Marshall Scholar, Marshall Aid Commemoration Commission, Government of the United 
Kingdom 
2009 
Truman Scholar, Harry S. Truman Scholarship Foundation 2008 
John T. McCraw Scholarship, National Federation of the Blind 2007 
 
National Honors and Awards 
 
Top 10 “newsworthy” abstracts for 2016, Association of Academic Physiatrists Annual 
Meeting, Association of Academic Physiatrists 
2015 
Medical student award, Rehabilitation Research Experience for Medical Students, 
Association of Academic Physiatrists 
2015 
Tarlov & Ware, Jr., Doctoral Dissertation and Award in Patient-Reported Outcomes, 
Health Assessment Laboratory/Medical Outcomes Trust 
2014 
Medical student award, Foundation for Anesthesia Education and Research (FAER) 2012 
Selected participant, Telluride Patient Safety Roundtable, The Academy for Emerging 
Leaders in Patient Safety 
2012 
Mary P. Oenslager National Achievement Award, Recording for the Blind and Dyslexic 2010 
Selected Truman Scholar delegate to the United Arab Emirates Cultural Exchange, Office 
of the Crown Prince of Abu Dhabi 
2009 
All-USA Academic First Team, USA Today 2008 
Outstanding Poster Award, American Association of Blood Banks 2007 
Patient Safety Research Award, Society for Simulation in Healthcare 2007 
 
Institutional Honors and Awards 
 
Honors on Ph.D. qualifying exam, Department of Health Policy and Management, Johns 
Hopkins Bloomberg School of Public Health 
2013 
Observatory Award, Green Templeton College, University of Oxford 2010 
Inductee, Phi Beta Kappa Honor Society 2009 
Dean’s List (all semesters), Johns Hopkins University 2009 
Mangefrieda-Swasey endowed Woodrow Wilson Fellowship, Johns Hopkins University 
Zanvyl Krieger School of Arts and Sciences 
2008 
Research Award, Bander Family International Fund, Johns Hopkins University 2008 
Appointed Member, Johns Hopkins Board of Trustees Presidential Search Committee 2008 
Merck Global Health Scholar, Merck & Co., Inc. 2008 
Inductee, Golden Key International Honor Society 2007 
Woodrow Wilson Research Fellowship, Johns Hopkins University, Zanvyl Krieger School 
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Mat Edelson. Focused intent. Johns Hopkins University Arts and Sciences Magazine. 2008;6(1). 
http://krieger.jhu.edu/magazine/f08/f1.html 
 
Amy Lunday. Johns Hopkins' Kurt Herzer wins Truman Scholarship. Johns Hopkins University News 
Release. May 5, 2008. http://pages.jh.edu/news_info/news/home08/may08/herzer.html 
 
Mary Beth Marklein. Great heights: these undergrads set on solving problems. USA Today. February 17, 
2008. http://usatoday30.usatoday.com/news/education/2008-02-13-college-allstars_N.htm 
 
Linda Wang. Teaching the blind and visually impaired is not a one-size-fits-all endeavor. Chemical and 






Invited Talks, Panels, and Seminars 
 
Nov 2015 Panelist, “Educating Faculty and Staff on Accommodations for Learners with 
Psychological Disabilities.” Association of American Medical College (AAMC) Annual 
Meeting: Learn Serve Lead, Baltimore, MD 
Mar 2015 Speaker, “Impact of Higher Medicare Spending on Patients’ Health, Functional 
Status, and Satisfaction with Health Care.” Health Economics Seminar, Johns 
Hopkins Bloomberg School of Public Health, Baltimore, MD 
Mar 2014 Speaker, “Improving Airway Management in Maryland Hospitals,” Presentation to 
Executive Leadership of Maryland Patient Safety Center, Baltimore, MD 
Mar 2014 Lead Facilitator, “Call a Colleague” Cross-Regional Discussion, as part of Learning 
Event for the Improving Health Outcomes: Blood Pressure Collaborative, Sponsored 
by the American Medical Association in collaboration with Johns Hopkins Medicine, 
Baltimore, MD 
Dec 2013 Presenter, “A Novel Quality Improvement Program for Managing Airway 
Emergencies: Difficult Airway Response Team.” Johns Hopkins Difficult Airway 
Research Group, Baltimore, MD 
Mar 2013 Keynote Speaker, “Empowering a Diverse Workforce Through Innovation,” YAI 
Business Advisory Council, New York, NY 
Oct 2012 Keynote Speaker, “The Future of Disability in America,” Department of Labor 
Employer Awards Breakfast, New York, NY 
May 2012 Keynote Speaker, “Unlocking Potential: Principles for Living and Working with a 
Visual Impairment,” Vision Rehabilitation and Employment Institute, Albany, NY 
Feb 2009 Facilitator, Focus Group Conference with UK Hospital CEOs: National Reporting 
and Learning System Risk Resiliency Model, London, United Kingdom 
Nov 2008 Invited Speaker, “Using Simulation to Improve Healthcare Quality,” Congreso 
Internacional de Salud (International Health Congress), Queretaro, Mexico 
April 2008 Invited Speaker, “President’s Welcome, Celebrating the Reunion Classes of 2008,” 
Johns Hopkins University, Baltimore, MD 
Dec 2007 Co-speaker, “Complex Airways in the Operating Room: A Continuous Quality 
Improvement Initiative,” Multidisciplinary Complex Airway Conference, Division of 
Invasive Pulmonary Medicine, Johns Hopkins University School of Medicine, 
Baltimore, MD 
Nov 2007 Panelist, “The Undergraduate Research Experience,” Johns Hopkins University, 
Baltimore, MD 
Sept 2007 Speaker, “Airway Response Team: Improving the Quality and Safety of Care 
Delivered to Airway-compromised Patients,” Patient Safety Committee, Johns 
Hopkins Hospital, Baltimore, MD  
Aug 2007 Speaker, United Kingdom Site Visit Presentation, Quality and Safety Research 
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Group, Johns Hopkins University, Baltimore, MD 
May 2007 Speaker, Lean Six Sigma Conference with the Ohio State University Fisher School 
of Business and Center for Operational Excellence, hosted by the Weinberg 
Perioperative Clinical Services Team, Baltimore, MD 
Oct 2006 Speaker, “Advancing Perioperative Care through Lean Six Sigma Methodologies,” 
Presentation to the Office of Risk Management, Johns Hopkins Hospital, Baltimore, 
MD 
Aug 2006 Speaker, “Perioperative Quality Management in the Academic Setting,” Resident 
Teaching Conference, Johns Hopkins Hospital, Baltimore, MD 
May 2006 Speaker, “Perioperative Clinical Services Team: Lean Six Sigma and Perioperative 
Services.” Presentation to Judy Reitz, COO, Office of the Executive Vice President 




Oct 2014 Invited participant, Johns Hopkins University Leadership Summit, Baltimore, MD 
Oct 2012 Invited participant, Johns Hopkins University Leadership Summit, Baltimore, MD 
June 2012 Invited participant, Patient Safety Roundtable, The Academy for Emerging Leaders 
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